| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain binding | 8.94e-07 | 11 | 147 | 4 | GO:0099122 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 1.10e-05 | 143 | 147 | 8 | GO:0017124 | |
| GeneOntologyMolecularFunction | actin binding | ESPN EVL WASL WASF3 INF2 FMN1 WASF2 ENAH PPP1R9B MICAL3 WIPF2 PALLD CAP2 KLHL17 | 1.25e-05 | 479 | 147 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | protein domain specific binding | SHANK1 ESPN EVL REPS1 RB1 SCAF8 ADGRB1 POU3F2 POU3F3 HCN2 AR CRK FMN1 WASF2 CASKIN1 ENAH IRS2 KLHL17 | 7.91e-05 | 875 | 147 | 18 | GO:0019904 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | CDX1 ZNF628 MAZ INSM1 ZBTB4 PDX1 POU3F2 POU3F3 SCX RAX AR HSF5 BPTF HOXB4 JUND HOXD11 MZF1 EGR4 NKX1-1 ZFHX3 LYL1 FOXC2 | 1.14e-04 | 1244 | 147 | 22 | GO:0000978 |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 1.26e-04 | 66 | 147 | 5 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 1.26e-04 | 66 | 147 | 5 | GO:0001098 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | CDX1 ZNF628 MAZ INSM1 ZBTB4 PDX1 POU3F2 POU3F3 SCX RAX AR HSF5 BPTF HOXB4 JUND HOXD11 MZF1 EGR4 NKX1-1 ZFHX3 LYL1 FOXC2 | 1.55e-04 | 1271 | 147 | 22 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | CDX1 ATF5 ZNF628 RB1 MAZ INSM1 ZBTB4 PDX1 POU3F2 POU3F3 SCX RAX AR HSF5 BPTF HOXB4 JUND HOXD11 MZF1 EGR4 NKX1-1 ZFHX3 LYL1 FOXC2 | 1.64e-04 | 1459 | 147 | 24 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II complex binding | 1.90e-04 | 39 | 147 | 4 | GO:0000993 | |
| GeneOntologyMolecularFunction | RNA polymerase core enzyme binding | 3.32e-04 | 45 | 147 | 4 | GO:0043175 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | SHANK1 BCL9L TCF20 RB1 INSM1 EWSR1 HCN2 AR SF1 CRK STRIP1 KMT2C JUND BRD4 EIF4G1 SMARCC1 SMARCC2 MICAL3 LTBP1 IRS2 BAG6 KLHL17 | 3.83e-04 | 1356 | 147 | 22 | GO:0060090 |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain phosphoserine binding | 5.31e-04 | 5 | 147 | 2 | GO:1990269 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | CDX1 ATF5 ZNF628 MAZ INSM1 ZBTB4 PDX1 POU3F2 POU3F3 SCX RAX AR HOXB2 HOXB4 JUND HOXD11 MZF1 EGR4 NKX1-1 ZFHX3 LYL1 FOXC2 | 6.61e-04 | 1412 | 147 | 22 | GO:0000981 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | CDX1 ATF5 ZNF628 POU3F2 SCX RAX AR HOXB2 JUND MZF1 EGR4 FOXC2 | 9.12e-04 | 560 | 147 | 12 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | CDX1 ATF5 ZNF628 POU3F2 SCX RAX AR HOXB2 JUND MZF1 EGR4 FOXC2 | 9.99e-04 | 566 | 147 | 12 | GO:0001216 |
| GeneOntologyMolecularFunction | chromatin binding | SAMD1 ATF5 MAZ INSM1 PDX1 AR SETDB1 TNRC18 PBRM1 BRD4 SMARCC1 SMARCC2 MBD5 FOXC2 | 1.14e-03 | 739 | 147 | 14 | GO:0003682 |
| GeneOntologyMolecularFunction | RNA polymerase binding | 1.35e-03 | 65 | 147 | 4 | GO:0070063 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 1.46e-03 | 8 | 147 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | RNA polymerase II CTD heptapeptide repeat kinase activity | 2.33e-03 | 10 | 147 | 2 | GO:0008353 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 2.33e-03 | 10 | 147 | 2 | GO:0140999 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | SHANK1 ESPN EVL WASL IQSEC2 MINK1 WASF3 ADGRB1 ARHGEF18 PLEKHG2 ZYX CRK STRIP1 INF2 FMN1 WASF2 ENAH PCDH15 PPP1R9B MICAL3 PALLD CAP2 ARAP1 KLHL17 | 1.68e-09 | 803 | 144 | 24 | GO:0030036 |
| GeneOntologyBiologicalProcess | actin filament-based process | SHANK1 ESPN EVL WASL IQSEC2 MINK1 WASF3 ADGRB1 ARHGEF18 PLEKHG2 ZYX CRK STRIP1 INF2 FMN1 WASF2 ENAH PCDH15 PPP1R9B MICAL3 PALLD CAP2 ARAP1 KLHL17 | 1.97e-08 | 912 | 144 | 24 | GO:0030029 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | IL11 BCL9L WASL CDX1 ATF5 TCF20 RB1 MAZ PDX1 POU3F2 POU3F3 SCX CCNK RAX AR BPTF KMT2C HOXB2 HOXB4 JUND MZF1 EGR4 BRD4 SMARCC1 ZFHX3 TNKS TAF4 MAPK7 FOXC2 | 8.99e-08 | 1390 | 144 | 29 | GO:0045944 |
| GeneOntologyBiologicalProcess | actin filament organization | SHANK1 ESPN EVL WASL WASF3 ARHGEF18 PLEKHG2 ZYX INF2 FMN1 WASF2 ENAH PCDH15 PPP1R9B MICAL3 CAP2 ARAP1 | 1.03e-07 | 509 | 144 | 17 | GO:0007015 |
| GeneOntologyBiologicalProcess | mRNA processing | CBLL1 CPSF6 SCAF8 HNRNPUL1 RBM20 SF1 HNRNPL SCAF4 ESRP2 RBM25 DAZAP1 PRPF40B RBM15B SMN1 RPRD2 SCAF11 SF3A2 | 3.17e-07 | 551 | 144 | 17 | GO:0006397 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | SHANK1 ESPN ADAMTS19 EVL WASL RB1 WASF3 ARHGEF18 PLEKHG2 SCX ZYX INF2 FMN1 WASF2 ENAH PCDH15 PPP1R9B SMN1 MICAL3 CAP2 ARAP1 FOXC2 | 8.28e-07 | 957 | 144 | 22 | GO:0097435 |
| GeneOntologyBiologicalProcess | RNA splicing | HNRNPUL1 PDCD7 RBM20 SF1 HNRNPL ESRP2 ZC3H10 RBM25 DAZAP1 PRPF40B RBM15B PPP1R9B SMN1 SCAF11 SF3A2 | 2.43e-06 | 502 | 144 | 15 | GO:0008380 |
| GeneOntologyBiologicalProcess | synapse organization | SHANK1 WASL PSD IQSEC2 WASF3 ADGRB1 ADGRL1 CRK ELFN1 WASF2 CASKIN1 EIF4G1 PPP1R9B NLGN2 BSN PALLD CAP2 | 6.09e-06 | 685 | 144 | 17 | GO:0050808 |
| GeneOntologyBiologicalProcess | actin nucleation | 6.14e-06 | 65 | 144 | 6 | GO:0045010 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | HNRNPUL1 RBM20 SF1 HNRNPL ESRP2 RBM25 DAZAP1 PRPF40B RBM15B SMN1 SCAF11 SF3A2 | 8.28e-06 | 358 | 144 | 12 | GO:0000398 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | HNRNPUL1 RBM20 SF1 HNRNPL ESRP2 RBM25 DAZAP1 PRPF40B RBM15B SMN1 SCAF11 SF3A2 | 8.28e-06 | 358 | 144 | 12 | GO:0000377 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | HNRNPUL1 RBM20 SF1 HNRNPL ESRP2 RBM25 DAZAP1 PRPF40B RBM15B SMN1 SCAF11 SF3A2 | 9.25e-06 | 362 | 144 | 12 | GO:0000375 |
| GeneOntologyBiologicalProcess | synapse assembly | PSD IQSEC2 ADGRB1 ADGRL1 CRK ELFN1 CASKIN1 EIF4G1 PPP1R9B NLGN2 BSN | 1.11e-05 | 308 | 144 | 11 | GO:0007416 |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 1.53e-05 | 207 | 144 | 9 | GO:0043484 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 1.91e-05 | 79 | 144 | 6 | GO:0000380 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | CBLL1 CPSF6 SCAF8 MAPKAPK2 HNRNPUL1 RBM20 SF1 HNRNPL SCAF4 ESRP2 RBM25 DAZAP1 PRPF40B RBM15B SMN1 RPRD2 SCAF11 TAF4 SF3A2 | 2.16e-05 | 917 | 144 | 19 | GO:0016071 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | SHANK1 ESPN EVL WASL PSD RB1 IQSEC2 INSM1 ADGRB1 ARHGEF18 ADGRL1 PLEKHG2 SETDB1 FMN1 WASF2 CASKIN1 EIF4G1 PPP1R9B NLGN2 ARAP1 WDR44 FOXC2 | 2.63e-05 | 1189 | 144 | 22 | GO:0044087 |
| GeneOntologyBiologicalProcess | actin polymerization or depolymerization | 2.67e-05 | 222 | 144 | 9 | GO:0008154 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled | 4.84e-05 | 2 | 144 | 2 | GO:2000805 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of RNA polymerase II transcription | 4.84e-05 | 2 | 144 | 2 | GO:0120191 | |
| GeneOntologyBiologicalProcess | cell junction organization | SHANK1 WASL PSD IQSEC2 WASF3 ADGRB1 PTPN23 ADGRL1 CRK ELFN1 FMN1 WASF2 CASKIN1 EIF4G1 PPP1R9B NLGN2 BSN PALLD CAP2 | 4.90e-05 | 974 | 144 | 19 | GO:0034330 |
| GeneOntologyBiologicalProcess | cell morphogenesis | SHANK1 BCL9L EVL WASL RB1 MINK1 WASF3 ADGRB1 ARHGEF18 POU3F2 AR SEMA4G CRK STRIP1 WASF2 ENAH PCDH15 SMN1 PALLD CAP2 ARAP1 | 8.47e-05 | 1194 | 144 | 21 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 8.89e-05 | 202 | 144 | 8 | GO:0051963 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription termination | 8.98e-05 | 34 | 144 | 4 | GO:0006353 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | SAMD1 ATF5 RB1 SCAF8 MAZ INSM1 ZBTB4 PDX1 POU3F3 SCX AR SF1 HNRNPL SCAF4 BPTF SETDB1 HOXB4 JUND MZF1 RBM15B SMARCC2 ZFHX3 FOXC2 | 1.04e-04 | 1399 | 144 | 23 | GO:0045892 |
| GeneOntologyBiologicalProcess | positive regulation of actin nucleation | 1.15e-04 | 14 | 144 | 3 | GO:0051127 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | SAMD1 ATF5 RB1 SCAF8 MAZ INSM1 ZBTB4 PDX1 POU3F3 SCX AR SF1 HNRNPL SCAF4 BPTF SETDB1 HOXB4 JUND MZF1 RBM15B SMARCC2 ZFHX3 FOXC2 | 1.21e-04 | 1413 | 144 | 23 | GO:1902679 |
| GeneOntologyBiologicalProcess | negative regulation of termination of DNA-templated transcription | 1.45e-04 | 3 | 144 | 2 | GO:0060567 | |
| GeneOntologyBiologicalProcess | termination of RNA polymerase II transcription, poly(A)-coupled | 1.45e-04 | 3 | 144 | 2 | GO:0030846 | |
| GeneOntologyBiologicalProcess | regulation of termination of RNA polymerase II transcription, poly(A)-coupled | 1.45e-04 | 3 | 144 | 2 | GO:2000804 | |
| GeneOntologyBiologicalProcess | termination of RNA polymerase II transcription | 1.75e-04 | 16 | 144 | 3 | GO:0006369 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | CBLL1 ESPN EVL WASL RB1 IQSEC2 WASF3 ADGRB1 PTPN23 ADGRL1 DGKD AR SETDB1 FMN1 WASF2 EIF4G1 SMPD1 TNKS NLGN2 SF3A2 ARAP1 FOXC2 | 2.01e-04 | 1366 | 144 | 22 | GO:0051130 |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | 2.11e-04 | 291 | 144 | 9 | GO:0032984 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | ESPN EVL WASL IQSEC2 ADGRB1 ADGRL1 SETDB1 FMN1 WASF2 EIF4G1 NLGN2 ARAP1 FOXC2 | 2.27e-04 | 582 | 144 | 13 | GO:0044089 |
| GeneOntologyBiologicalProcess | negative regulation of actin filament bundle assembly | 2.72e-04 | 45 | 144 | 4 | GO:0032232 | |
| GeneOntologyBiologicalProcess | regulation of termination of RNA polymerase II transcription | 2.88e-04 | 4 | 144 | 2 | GO:1904594 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 2.93e-04 | 129 | 144 | 6 | GO:0048024 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 3.29e-04 | 309 | 144 | 9 | GO:1901888 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 3.61e-04 | 313 | 144 | 9 | GO:0099173 | |
| GeneOntologyBiologicalProcess | myoblast differentiation | 3.89e-04 | 136 | 144 | 6 | GO:0045445 | |
| GeneOntologyBiologicalProcess | actin filament bundle assembly | 3.95e-04 | 191 | 144 | 7 | GO:0051017 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | SAMD1 RB1 SCAF8 MAZ INSM1 ZBTB4 PDX1 POU3F3 AR SCAF4 BPTF SETDB1 HOXB4 JUND MZF1 SMARCC2 ZFHX3 FOXC2 | 3.99e-04 | 1053 | 144 | 18 | GO:0000122 |
| GeneOntologyBiologicalProcess | actin filament bundle organization | 4.47e-04 | 195 | 144 | 7 | GO:0061572 | |
| GeneOntologyBiologicalProcess | synaptic vesicle clustering | 4.66e-04 | 22 | 144 | 3 | GO:0097091 | |
| GeneOntologyBiologicalProcess | positive regulation of clathrin-dependent endocytosis | 4.77e-04 | 5 | 144 | 2 | GO:2000370 | |
| GeneOntologyBiologicalProcess | postsynapse assembly | 4.91e-04 | 93 | 144 | 5 | GO:0099068 | |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 5.50e-04 | 54 | 144 | 4 | GO:0045663 | |
| GeneOntologyBiologicalProcess | cell junction assembly | PSD IQSEC2 ADGRB1 ADGRL1 CRK ELFN1 FMN1 CASKIN1 EIF4G1 PPP1R9B NLGN2 BSN | 6.60e-04 | 569 | 144 | 12 | GO:0034329 |
| GeneOntologyBiologicalProcess | regulation of AMPA receptor activity | 6.85e-04 | 25 | 144 | 3 | GO:2000311 | |
| GeneOntologyBiologicalProcess | forebrain ventricular zone progenitor cell division | 7.13e-04 | 6 | 144 | 2 | GO:0021869 | |
| GeneOntologyBiologicalProcess | regulation of termination of DNA-templated transcription | 7.13e-04 | 6 | 144 | 2 | GO:0031554 | |
| GeneOntologyBiologicalProcess | regulation of alternative mRNA splicing, via spliceosome | 7.70e-04 | 59 | 144 | 4 | GO:0000381 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 8.59e-04 | 158 | 144 | 6 | GO:0050684 | |
| GeneOntologyCellularComponent | nuclear body | CBLL1 SETD1B TCF20 RB1 CPSF6 ZBTB4 PDX1 PTPN23 EWSR1 PNISR AR SF1 RBM25 PRPF40B RBM15B SMN1 ZFHX3 SCAF11 TNKS MAPK7 SF3A2 FOXC2 | 2.19e-07 | 903 | 143 | 22 | GO:0016604 |
| GeneOntologyCellularComponent | SWI/SNF complex | 1.73e-06 | 30 | 143 | 5 | GO:0016514 | |
| GeneOntologyCellularComponent | chromatin | CDX1 ATF5 RB1 CPSF6 BICRA PDX1 POU3F2 POU3F3 SCX RAX AR HNRNPL BPTF HOXB2 HOXB4 JUND PBRM1 HOXD11 EGR4 BRD4 SMARCC1 NKX1-1 SMARCC2 ZFHX3 TAF4 LYL1 FOXC2 | 2.44e-06 | 1480 | 143 | 27 | GO:0000785 |
| GeneOntologyCellularComponent | cyclin/CDK positive transcription elongation factor complex | 2.55e-05 | 9 | 143 | 3 | GO:0008024 | |
| GeneOntologyCellularComponent | postsynaptic specialization | SHANK1 PSD IQSEC2 MINK1 ADGRB1 PRR12 ELFN1 SYN2 PPP1R9B NLGN2 BSN CAP2 KLHL17 | 4.32e-05 | 503 | 143 | 13 | GO:0099572 |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 5.16e-05 | 96 | 143 | 6 | GO:0070603 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | SHANK1 PSD IQSEC2 MINK1 ADGRB1 PRR12 ELFN1 SYN2 PPP1R9B NLGN2 BSN CAP2 KLHL17 | 6.43e-05 | 523 | 143 | 13 | GO:0098984 |
| GeneOntologyCellularComponent | postsynaptic density | SHANK1 PSD IQSEC2 MINK1 ADGRB1 PRR12 ELFN1 SYN2 PPP1R9B BSN CAP2 KLHL17 | 6.52e-05 | 451 | 143 | 12 | GO:0014069 |
| GeneOntologyCellularComponent | asymmetric synapse | SHANK1 PSD IQSEC2 MINK1 ADGRB1 PRR12 ELFN1 SYN2 PPP1R9B BSN CAP2 KLHL17 | 1.11e-04 | 477 | 143 | 12 | GO:0032279 |
| GeneOntologyCellularComponent | RSC-type complex | 1.34e-04 | 15 | 143 | 3 | GO:0016586 | |
| GeneOntologyCellularComponent | actin cytoskeleton | ESPN EVL WASL BAG3 ZYX CRK INF2 FMN1 WASF2 ENAH PPP1R9B PALLD KLHL17 | 1.68e-04 | 576 | 143 | 13 | GO:0015629 |
| GeneOntologyCellularComponent | lamellipodium | 1.89e-04 | 230 | 143 | 8 | GO:0030027 | |
| GeneOntologyCellularComponent | nuclear cyclin-dependent protein kinase holoenzyme complex | 2.37e-04 | 18 | 143 | 3 | GO:0019908 | |
| GeneOntologyCellularComponent | ATPase complex | 2.63e-04 | 129 | 143 | 6 | GO:1904949 | |
| GeneOntologyCellularComponent | dendrite | SHANK1 PSD MINK1 ADGRB1 LMTK3 HCN2 AR BPTF ELFN1 PPP1R9B NLGN2 LTBP1 BSN DMWD HRH3 KLHL17 | 2.65e-04 | 858 | 143 | 16 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | SHANK1 PSD MINK1 ADGRB1 LMTK3 HCN2 AR BPTF ELFN1 PPP1R9B NLGN2 LTBP1 BSN DMWD HRH3 KLHL17 | 2.72e-04 | 860 | 143 | 16 | GO:0097447 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | BCL9L ATF5 SETD1B RB1 CPSF6 SCAF8 BICRA PDCD7 CCNK SF1 BPTF KMT2C JUND PBRM1 PRPF40B BRD4 SMARCC1 SMARCC2 TNKS TAF4 SF3A2 | 4.47e-04 | 1377 | 143 | 21 | GO:0140513 |
| GeneOntologyCellularComponent | carboxy-terminal domain protein kinase complex | 5.71e-04 | 24 | 143 | 3 | GO:0032806 | |
| GeneOntologyCellularComponent | postsynapse | SHANK1 WASL PSD IQSEC2 MINK1 WASF3 ADGRB1 PRR12 ELFN1 CASKIN1 EIF4G1 SYN2 PPP1R9B NLGN2 BSN CAP2 KLHL17 | 6.02e-04 | 1018 | 143 | 17 | GO:0098794 |
| GeneOntologyCellularComponent | somatodendritic compartment | SHANK1 PSD MINK1 ADGRB1 LMTK3 HCN2 AR BPTF ELFN1 KCNN1 PPP1R9B SMN1 NLGN2 LTBP1 BSN DMWD PALLD HRH3 KLHL17 | 7.19e-04 | 1228 | 143 | 19 | GO:0036477 |
| GeneOntologyCellularComponent | nuclear speck | 7.82e-04 | 431 | 143 | 10 | GO:0016607 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 8.49e-04 | 107 | 143 | 5 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 8.49e-04 | 107 | 143 | 5 | GO:0001725 | |
| GeneOntologyCellularComponent | excitatory synapse | 8.49e-04 | 107 | 143 | 5 | GO:0060076 | |
| GeneOntologyCellularComponent | methyltransferase complex | 8.85e-04 | 108 | 143 | 5 | GO:0034708 | |
| GeneOntologyCellularComponent | U2AF complex | 9.54e-04 | 7 | 143 | 2 | GO:0089701 | |
| GeneOntologyCellularComponent | actomyosin | 1.27e-03 | 117 | 143 | 5 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 1.32e-03 | 118 | 143 | 5 | GO:0032432 | |
| GeneOntologyCellularComponent | ribbon synapse | 1.34e-03 | 32 | 143 | 3 | GO:0097470 | |
| GeneOntologyCellularComponent | RNA N6-methyladenosine methyltransferase complex | 1.62e-03 | 9 | 143 | 2 | GO:0036396 | |
| GeneOntologyCellularComponent | cell leading edge | 2.35e-03 | 500 | 143 | 10 | GO:0031252 | |
| GeneOntologyCellularComponent | SCAR complex | 2.93e-03 | 12 | 143 | 2 | GO:0031209 | |
| GeneOntologyCellularComponent | npBAF complex | 4.01e-03 | 14 | 143 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | GBAF complex | 4.01e-03 | 14 | 143 | 2 | GO:0140288 | |
| GeneOntologyCellularComponent | brahma complex | 4.01e-03 | 14 | 143 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | nBAF complex | 5.24e-03 | 16 | 143 | 2 | GO:0071565 | |
| HumanPheno | Ewing sarcoma | 2.39e-06 | 4 | 44 | 3 | HP:0012254 | |
| HumanPheno | Diagnostic behavioral phenotype | ESPN SETD1B TCF20 OTUD5 BICRA IQSEC2 ADGRL1 POU3F3 CCNK SCAF4 KMT2C BRD4 EIF4G1 PCDH15 SYN2 SMARCC2 SMPD1 TAF4 MBD5 | 4.33e-06 | 747 | 44 | 19 | HP:0025783 |
| HumanPheno | Thick eyebrow | 4.09e-05 | 154 | 44 | 8 | HP:0000574 | |
| MousePheno | abnormal social/conspecific interaction behavior | SHANK1 ESPN TCF20 IQSEC2 ADGRL1 LMTK3 AR HOXB2 JUND CASKIN1 EIF4G1 PCDH15 SYN2 NLGN2 IRS2 MBD5 KLHL17 | 2.02e-07 | 421 | 125 | 17 | MP:0002557 |
| MousePheno | decreased growth hormone level | 1.38e-05 | 35 | 125 | 5 | MP:0005136 | |
| MousePheno | decreased pituitary hormone level | 6.81e-05 | 113 | 125 | 7 | MP:0003972 | |
| MousePheno | increased PP cell number | 7.93e-05 | 2 | 125 | 2 | MP:0009185 | |
| MousePheno | abnormal pancreatic endocrine progenitor cell physiology | 7.93e-05 | 2 | 125 | 2 | MP:0011911 | |
| Domain | WH2 | 5.63e-10 | 14 | 145 | 6 | SM00246 | |
| Domain | WH2 | 1.48e-09 | 16 | 145 | 6 | PF02205 | |
| Domain | WH2_dom | 9.73e-09 | 21 | 145 | 6 | IPR003124 | |
| Domain | WH2 | 2.37e-08 | 24 | 145 | 6 | PS51082 | |
| Domain | RNA_pol_II-bd | 1.20e-07 | 7 | 145 | 4 | IPR006903 | |
| Domain | CTD_bind | 1.20e-07 | 7 | 145 | 4 | PF04818 | |
| Domain | RPR | 2.38e-07 | 8 | 145 | 4 | SM00582 | |
| Domain | CID_dom | 2.38e-07 | 8 | 145 | 4 | IPR006569 | |
| Domain | CID | 2.38e-07 | 8 | 145 | 4 | PS51391 | |
| Domain | RRM | SETD1B CPSF6 SCAF8 EWSR1 RBM20 HNRNPL SCAF4 ESRP2 RBM25 DAZAP1 RBM15B | 1.05e-06 | 217 | 145 | 11 | SM00360 |
| Domain | WH1 | 1.10e-06 | 11 | 145 | 4 | SM00461 | |
| Domain | WH1/EVH1_dom | 1.10e-06 | 11 | 145 | 4 | IPR000697 | |
| Domain | WH1 | 1.10e-06 | 11 | 145 | 4 | PF00568 | |
| Domain | RRM_dom | SETD1B CPSF6 SCAF8 EWSR1 RBM20 HNRNPL SCAF4 ESRP2 RBM25 DAZAP1 RBM15B | 1.63e-06 | 227 | 145 | 11 | IPR000504 |
| Domain | RRM | SETD1B CPSF6 SCAF8 EWSR1 RBM20 HNRNPL SCAF4 ESRP2 RBM25 DAZAP1 RBM15B | 1.85e-06 | 230 | 145 | 11 | PS50102 |
| Domain | Homeobox_CS | 1.94e-06 | 186 | 145 | 10 | IPR017970 | |
| Domain | WH1 | 2.36e-06 | 13 | 145 | 4 | PS50229 | |
| Domain | - | SETD1B CPSF6 SCAF8 EWSR1 RBM20 HNRNPL SCAF4 ESRP2 RBM25 DAZAP1 RBM15B | 3.28e-06 | 244 | 145 | 11 | 3.30.70.330 |
| Domain | RRM_1 | SETD1B CPSF6 SCAF8 EWSR1 HNRNPL SCAF4 ESRP2 RBM25 DAZAP1 RBM15B | 5.28e-06 | 208 | 145 | 10 | PF00076 |
| Domain | Nucleotide-bd_a/b_plait | SETD1B CPSF6 SCAF8 EWSR1 RBM20 HNRNPL SCAF4 ESRP2 RBM25 DAZAP1 RBM15B | 5.59e-06 | 258 | 145 | 11 | IPR012677 |
| Domain | SAM | 1.05e-05 | 97 | 145 | 7 | IPR001660 | |
| Domain | Homeodomain-like | CDX1 PDX1 POU3F2 POU3F3 RAX HOXB2 HOXB4 HOXD11 SMARCC1 NKX1-1 SMARCC2 ZFHX3 | 1.11e-05 | 332 | 145 | 12 | IPR009057 |
| Domain | - | CDX1 PDX1 POU3F2 POU3F3 RAX HOXB2 HOXB4 HOXD11 SMARCC1 SMARCC2 ZFHX3 | 1.34e-05 | 283 | 145 | 11 | 1.10.10.60 |
| Domain | Homeobox | 1.48e-05 | 234 | 145 | 10 | PF00046 | |
| Domain | HOMEOBOX_1 | 1.59e-05 | 236 | 145 | 10 | PS00027 | |
| Domain | HOX | 1.65e-05 | 237 | 145 | 10 | SM00389 | |
| Domain | HOMEOBOX_2 | 1.78e-05 | 239 | 145 | 10 | PS50071 | |
| Domain | Homeobox_dom | 1.78e-05 | 239 | 145 | 10 | IPR001356 | |
| Domain | - | 1.89e-05 | 106 | 145 | 7 | 1.10.150.50 | |
| Domain | SAM/pointed | 3.58e-05 | 117 | 145 | 7 | IPR013761 | |
| Domain | - | 4.56e-05 | 26 | 145 | 4 | 1.25.40.90 | |
| Domain | - | EVL WASL PSD IQSEC2 ARHGEF18 DGKD PLEKHG2 SPRED3 ENAH IRS2 APBB1IP ARAP1 | 5.54e-05 | 391 | 145 | 12 | 2.30.29.30 |
| Domain | SMARCC_C | 5.99e-05 | 2 | 145 | 2 | IPR032451 | |
| Domain | SMARCC_N | 5.99e-05 | 2 | 145 | 2 | IPR032450 | |
| Domain | SWIRM-assoc | 5.99e-05 | 2 | 145 | 2 | IPR032448 | |
| Domain | SWIRM-assoc_2 | 5.99e-05 | 2 | 145 | 2 | PF16496 | |
| Domain | SWIRM-assoc_1 | 5.99e-05 | 2 | 145 | 2 | PF16495 | |
| Domain | SWIRM-assoc_3 | 5.99e-05 | 2 | 145 | 2 | PF16498 | |
| Domain | SAM | 6.34e-05 | 88 | 145 | 6 | SM00454 | |
| Domain | Znf_U1 | 7.12e-05 | 29 | 145 | 4 | IPR003604 | |
| Domain | ENTH_VHS | 7.12e-05 | 29 | 145 | 4 | IPR008942 | |
| Domain | ZnF_U1 | 7.12e-05 | 29 | 145 | 4 | SM00451 | |
| Domain | Homeobox_metazoa | 7.19e-05 | 90 | 145 | 6 | IPR020479 | |
| Domain | HMGI/Y_DNA-bd_CS | 9.32e-05 | 31 | 145 | 4 | IPR000637 | |
| Domain | SAM_DOMAIN | 9.72e-05 | 95 | 145 | 6 | PS50105 | |
| Domain | PH_dom-like | EVL WASL PSD IQSEC2 ARHGEF18 DGKD PLEKHG2 SPRED3 ENAH IRS2 APBB1IP ARAP1 | 1.25e-04 | 426 | 145 | 12 | IPR011993 |
| Domain | VASP_tetra | 1.79e-04 | 3 | 145 | 2 | PF08776 | |
| Domain | SCAR/WAVE_fam | 1.79e-04 | 3 | 145 | 2 | IPR028288 | |
| Domain | PROL5-SMR | 1.79e-04 | 3 | 145 | 2 | PF15621 | |
| Domain | VASP_tetra | 1.79e-04 | 3 | 145 | 2 | IPR014885 | |
| Domain | SMR-like | 1.79e-04 | 3 | 145 | 2 | IPR026288 | |
| Domain | SAM_1 | 1.85e-04 | 68 | 145 | 5 | PF00536 | |
| Domain | Post-SET_dom | 2.38e-04 | 16 | 145 | 3 | IPR003616 | |
| Domain | PostSET | 2.38e-04 | 16 | 145 | 3 | SM00508 | |
| Domain | POST_SET | 2.38e-04 | 16 | 145 | 3 | PS50868 | |
| Domain | TF_POU_3 | 3.56e-04 | 4 | 145 | 2 | IPR016362 | |
| Domain | ANTENNAPEDIA | 8.23e-04 | 24 | 145 | 3 | PS00032 | |
| Domain | SWIRM | 8.80e-04 | 6 | 145 | 2 | PS50934 | |
| Domain | SWIRM | 8.80e-04 | 6 | 145 | 2 | PF04433 | |
| Domain | SWIRM | 8.80e-04 | 6 | 145 | 2 | IPR007526 | |
| Domain | Bromodomain_CS | 1.05e-03 | 26 | 145 | 3 | IPR018359 | |
| Domain | PH | 1.50e-03 | 278 | 145 | 8 | SM00233 | |
| Domain | PH_DOMAIN | 1.53e-03 | 279 | 145 | 8 | PS50003 | |
| Domain | PH_domain | 1.57e-03 | 280 | 145 | 8 | IPR001849 | |
| Domain | PH | 2.10e-03 | 229 | 145 | 7 | PF00169 | |
| Domain | BROMODOMAIN_1 | 2.94e-03 | 37 | 145 | 3 | PS00633 | |
| Domain | BAH | 3.14e-03 | 11 | 145 | 2 | PS51038 | |
| Domain | BAH_dom | 3.14e-03 | 11 | 145 | 2 | IPR001025 | |
| Domain | MBD | 3.14e-03 | 11 | 145 | 2 | SM00391 | |
| Domain | MBD | 3.14e-03 | 11 | 145 | 2 | PS50982 | |
| Domain | BAH | 3.14e-03 | 11 | 145 | 2 | SM00439 | |
| Domain | GAIN_dom_N | 3.14e-03 | 11 | 145 | 2 | IPR032471 | |
| Domain | Methyl_CpG_DNA-bd | 3.14e-03 | 11 | 145 | 2 | IPR001739 | |
| Domain | MBD | 3.14e-03 | 11 | 145 | 2 | PF01429 | |
| Domain | BAH | 3.14e-03 | 11 | 145 | 2 | PF01426 | |
| Domain | DNA-bd_dom | 3.14e-03 | 11 | 145 | 2 | IPR016177 | |
| Domain | GAIN | 3.14e-03 | 11 | 145 | 2 | PF16489 | |
| Domain | Bromodomain | 3.17e-03 | 38 | 145 | 3 | PF00439 | |
| Domain | CYCLIN | 3.17e-03 | 38 | 145 | 3 | SM00385 | |
| Domain | - | 3.67e-03 | 40 | 145 | 3 | 1.10.472.10 | |
| Domain | Znf_C2H2_matrin | 3.75e-03 | 12 | 145 | 2 | IPR000690 | |
| Domain | Homeobox_antennapedia | 3.75e-03 | 12 | 145 | 2 | IPR017995 | |
| Domain | SET | 3.94e-03 | 41 | 145 | 3 | PF00856 | |
| Domain | BROMODOMAIN_2 | 3.94e-03 | 41 | 145 | 3 | PS50014 | |
| Domain | Bromodomain | 4.22e-03 | 42 | 145 | 3 | IPR001487 | |
| Domain | BROMO | 4.22e-03 | 42 | 145 | 3 | SM00297 | |
| Domain | - | 4.22e-03 | 42 | 145 | 3 | 1.20.920.10 | |
| Domain | Cyclin-like | 4.51e-03 | 43 | 145 | 3 | IPR013763 | |
| Domain | SET | 5.45e-03 | 46 | 145 | 3 | SM00317 | |
| Domain | WW | 5.79e-03 | 47 | 145 | 3 | PF00397 | |
| Domain | Znf_FYVE_PHD | 5.83e-03 | 147 | 145 | 5 | IPR011011 | |
| Domain | FH2 | 5.88e-03 | 15 | 145 | 2 | PS51444 | |
| Domain | FH2_Formin | 5.88e-03 | 15 | 145 | 2 | IPR015425 | |
| Domain | FH2 | 5.88e-03 | 15 | 145 | 2 | PF02181 | |
| Domain | - | 5.88e-03 | 15 | 145 | 2 | 1.10.1000.11 | |
| Domain | Sec7 | 5.88e-03 | 15 | 145 | 2 | PF01369 | |
| Domain | Sec7_alpha_orthog | 5.88e-03 | 15 | 145 | 2 | IPR023394 | |
| Domain | FH2 | 5.88e-03 | 15 | 145 | 2 | SM00498 | |
| Domain | WW | 6.14e-03 | 48 | 145 | 3 | SM00456 | |
| Domain | POU | 6.69e-03 | 16 | 145 | 2 | SM00352 | |
| Pathway | BIOCARTA_ACTINY_PATHWAY | 5.19e-05 | 10 | 109 | 3 | MM1528 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 6.92e-05 | 29 | 109 | 4 | M48076 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 7.98e-05 | 134 | 109 | 7 | M3574 | |
| Pathway | BIOCARTA_ACTINY_PATHWAY | 9.40e-05 | 12 | 109 | 3 | M7825 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | 1.06e-04 | 61 | 109 | 5 | M152 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES | 1.65e-04 | 36 | 109 | 4 | M27549 | |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | EVL WASL CHERP REPS1 CPSF6 EWSR1 HNRNPUL1 CCNK SF1 HNRNPL SCAF4 DAZAP1 WASF2 BRD4 ENAH SMARCC1 SMARCC2 RPRD2 WIPF2 SF3A2 APBB1IP | 1.08e-25 | 154 | 149 | 21 | 16055720 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | EVL TCF20 OTUD5 SCAF8 MINK1 BAG3 FNBP4 HNRNPUL1 PNISR CCNK ZYX SF1 STRIP1 SCAF4 BPTF JUND RBM25 BRD4 EIF4G1 RBM15B SMARCC1 SMARCC2 MICAL3 SCAF11 IRS2 DMWD PRRC2A BAG6 WDR44 | 3.69e-19 | 774 | 149 | 29 | 15302935 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TBKBP1 SETD1B REPS1 ZNF628 MAPKAPK2 BICRA RNPEPL1 ZBTB4 ADGRL1 FBXO46 C6orf132 ESRP2 ZCCHC14 PRR12 NHSL1 KMT2C HOXB4 JUND TNRC18 INF2 CASKIN1 BRD4 EIF4G1 MICAL3 NLGN2 IRS2 MBD5 DMWD ARAP1 KLHL17 | 5.43e-16 | 1105 | 149 | 30 | 35748872 |
| Pubmed | WASL CHERP CPSF6 FNBP4 PNISR CCNK ZYX SF1 SCAF4 RBM25 INF2 WASF2 BRD4 ENAH SMARCC1 SMARCC2 RPRD2 WIPF2 SF3A2 CAP2 | 6.93e-14 | 506 | 149 | 20 | 30890647 | |
| Pubmed | CHERP CPSF6 BICRA BAG3 EWSR1 ZYX SF1 HNRNPL RBM25 DAZAP1 BRD4 SMARCC1 SMARCC2 RPRD2 PRRC2A BAG6 PALLD SF3A2 | 1.44e-13 | 399 | 149 | 18 | 35987950 | |
| Pubmed | REPS1 TCF20 BAG3 FNBP4 PTPN23 CCNK ZYX CRK SCAF4 BPTF KMT2C RBM25 BRD4 ENAH SMARCC1 RPRD2 TAF4 PRRC2A PALLD WDR44 | 3.13e-13 | 549 | 149 | 20 | 38280479 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CBLL1 CHERP TCF20 CPSF6 BICRA MAZ FNBP4 EWSR1 HNRNPUL1 CCNK SF1 HNRNPL SCAF4 BPTF RBM25 DAZAP1 BRD4 EIF4G1 RBM15B SMARCC1 SMARCC2 RPRD2 SCAF11 TAF4 PRRC2A | 4.30e-13 | 954 | 149 | 25 | 36373674 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ESPN CABLES2 EVL TBKBP1 SCAF8 MAPKAPK2 BICRA MINK1 WASF3 FNBP4 ARHGEF18 ADGRL1 AR HNRNPL BPTF KMT2C TNRC18 DAZAP1 INF2 ENAH PPP1R9B ZFHX3 RPRD2 MICAL3 SCAF11 NLGN2 TAF4 MBD5 CAP2 ARAP1 | 1.24e-12 | 1489 | 149 | 30 | 28611215 |
| Pubmed | BCL9L TCF20 RB1 SCAF8 BICRA MAZ EWSR1 HNRNPUL1 RBM20 HNRNPL SCAF4 PRR12 BPTF KMT2C SETDB1 JUND RBM25 PBRM1 HOXD11 EIF4G1 SMARCC1 SMARCC2 SMN1 ZFHX3 RPRD2 SCAF11 TAF4 R3HDM1 PRRC2A | 2.63e-12 | 1429 | 149 | 29 | 35140242 | |
| Pubmed | SHANK1 CBLL1 TCF20 IQSEC2 MINK1 ARHGEF18 EWSR1 LMTK3 HCN2 STRIP1 PBRM1 WASF2 CASKIN1 ENAH EIF4G1 SMARCC1 SMARCC2 PPP1R9B TNKS NLGN2 TAF4 BSN PRRC2A CAP2 | 3.82e-12 | 963 | 149 | 24 | 28671696 | |
| Pubmed | EVL TCF20 CPSF6 BICRA EWSR1 HNRNPUL1 CCNK ZYX SF1 HNRNPL SCAF4 PRR12 ZC3H10 BPTF KMT2C JUND TNRC18 DAZAP1 BRD4 SMARCC1 SMARCC2 TAF4 PRRC2A BAG6 SF3A2 | 1.00e-11 | 1103 | 149 | 25 | 34189442 | |
| Pubmed | WASL CPSF6 SCAF8 HNRNPUL1 PDCD7 SCAF4 DAZAP1 ENAH SMARCC1 RPRD2 WIPF2 PRRC2A SF3A2 | 1.43e-11 | 220 | 149 | 13 | 24550385 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | CBLL1 CHERP TCF20 CPSF6 MAZ FNBP4 EWSR1 HNRNPUL1 LMTK3 PDCD7 PNISR CCNK SF1 HNRNPL SCAF4 BPTF RBM25 BRD4 EIF4G1 PCDH15 RBM15B SMARCC1 SMARCC2 SF3A2 | 4.24e-11 | 1082 | 149 | 24 | 38697112 |
| Pubmed | BCL9L CHERP TCF20 CPSF6 CCNK AR PRR12 TNRC18 PBRM1 BRD4 SMARCC1 SMARCC2 RPRD2 | 1.66e-10 | 268 | 149 | 13 | 33640491 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | SAMD1 TCF20 RB1 BICRA MAZ RBM20 PRR12 KMT2C HOXB2 TNRC18 PBRM1 BRD4 SMARCC1 SMARCC2 TNKS | 2.11e-10 | 398 | 149 | 15 | 35016035 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CBLL1 SAMD1 CHERP TCF20 MAZ FNBP4 EWSR1 HNRNPUL1 PNISR SF1 HNRNPL SCAF4 PRR12 BPTF KMT2C JUND RBM25 PBRM1 BRD4 RBM15B SMARCC1 RPRD2 SCAF11 TAF4 SF3A2 | 2.88e-10 | 1294 | 149 | 25 | 30804502 |
| Pubmed | SHANK1 WASL TCF20 BICRA BAG3 PTPN23 ADGRL1 PNISR ZYX KMT2C SETDB1 MAPK7 MBD5 WIPF2 CAP2 WDR44 | 3.69e-10 | 486 | 149 | 16 | 20936779 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | BCL9L CHERP TCF20 CPSF6 SCAF8 EWSR1 SF1 ESRP2 PRR12 RPRD2 R3HDM1 | 3.90e-10 | 180 | 149 | 11 | 35198878 |
| Pubmed | WASL REPS1 MAZ BAG3 ARHGEF18 PLEKHG2 ZYX SF1 CRK RBM25 DAZAP1 ENAH SMARCC1 SMARCC2 PPP1R9B SMN1 TNKS WIPF2 PRRC2A SF3A2 ARAP1 | 4.37e-10 | 916 | 149 | 21 | 32203420 | |
| Pubmed | BCL9L TCF20 BICRA MAZ BAG3 FNBP4 EWSR1 PNISR PRR12 DAZAP1 SMARCC1 SMARCC2 TAF4 R3HDM1 BAG6 | 5.22e-10 | 425 | 149 | 15 | 24999758 | |
| Pubmed | SETD1B CPSF6 HNRNPUL1 PDCD7 PNISR CCNK SCAF4 BPTF KMT2C RBM15B SMARCC1 SCAF11 | 1.02e-09 | 251 | 149 | 12 | 31076518 | |
| Pubmed | CBLL1 BCL9L SAMD1 REPS1 CPSF6 SCAF8 MAZ MINK1 PDCD7 PNISR CCNK STRIP1 C6orf132 SCAF4 PRR12 KMT2C PBRM1 WASF2 EIF4G1 RBM15B SMN1 ZFHX3 SCAF11 TAF4 PRRC2A SF3A2 | 1.16e-09 | 1497 | 149 | 26 | 31527615 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | SHANK1 EVL SAMD1 ADGRL1 DGKD EWSR1 HNRNPUL1 PRR13 KCNN1 SMARCC2 PPP1R9B SMN1 RPRD2 LTBP1 MAPK7 R3HDM1 | 2.82e-09 | 560 | 149 | 16 | 21653829 |
| Pubmed | TMEM121B MINK1 ADGRL1 LMTK3 HCN2 STRIP1 CASKIN1 SYN2 MICAL3 NLGN2 BSN PRRC2A CAP2 | 3.84e-09 | 347 | 149 | 13 | 17114649 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | BCL9L TBKBP1 TCF20 BICRA PRR12 BPTF KMT2C TNRC18 PBRM1 SMARCC1 SMARCC2 ZFHX3 TAF4 | 4.40e-09 | 351 | 149 | 13 | 38297188 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | CHERP CPSF6 MAZ EWSR1 HNRNPUL1 PNISR SF1 HNRNPL SCAF4 ESRP2 RBM25 MEX3A DAZAP1 RBM15B SCAF11 R3HDM1 PRRC2A SF3A2 | 1.29e-08 | 807 | 149 | 18 | 22681889 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | CDX1 ATF5 MAZ INSM1 ZBTB4 PDX1 POU3F2 POU3F3 RAX AR HSF5 HOXB2 HOXB4 JUND HOXD11 MZF1 ZFHX3 LYL1 FOXC2 | 1.38e-08 | 908 | 149 | 19 | 19274049 |
| Pubmed | CBLL1 BCL9L CPSF6 MAZ CCNK BPTF KMT2C PBRM1 DAZAP1 BRD4 SMARCC1 SMARCC2 SCAF11 BAG6 | 1.68e-08 | 469 | 149 | 14 | 27634302 | |
| Pubmed | 2.25e-08 | 153 | 149 | 9 | 28225217 | ||
| Pubmed | CHERP TCF20 EWSR1 HNRNPUL1 HNRNPL EIF4G1 SMARCC1 SMARCC2 PPP1R9B R3HDM1 PRRC2A | 3.14e-08 | 274 | 149 | 11 | 34244482 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TCF20 MAZ IQSEC2 MINK1 BAG3 PLEKHG2 HNRNPUL1 ZYX C6orf132 ZCCHC14 USP31 NHSL1 BRD4 EIF4G1 SIK2 IRS2 R3HDM1 PALLD | 3.46e-08 | 861 | 149 | 18 | 36931259 |
| Pubmed | BAG3 ZYX SF1 STRIP1 RBM25 PBRM1 ENAH EIF4G1 RPRD2 IRS2 PRRC2A BAG6 PALLD WDR44 | 4.01e-08 | 503 | 149 | 14 | 16964243 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | TCF20 HNRNPUL1 AR HNRNPL KMT2C RBM25 PBRM1 DAZAP1 SMARCC1 ZFHX3 | 4.24e-08 | 220 | 149 | 10 | 35785414 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 4.36e-08 | 283 | 149 | 11 | 30585729 | |
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 21769917 | ||
| Pubmed | Analysis of the Histone H3.1 Interactome: A Suitable Chaperone for the Right Event. | 1.00e-07 | 182 | 149 | 9 | 26527279 | |
| Pubmed | 1.01e-07 | 27 | 149 | 5 | 29374058 | ||
| Pubmed | CHERP EWSR1 HNRNPUL1 HNRNPL RBM25 PBRM1 SMARCC2 SMN1 SCAF11 PRRC2A | 1.12e-07 | 244 | 149 | 10 | 29884807 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | CHERP REPS1 CPSF6 BAG3 PTPN23 HNRNPUL1 CCNK ZYX SF1 SCAF4 WASF2 ENAH PPP1R9B RPRD2 IRS2 PRRC2A PALLD WDR44 | 1.16e-07 | 934 | 149 | 18 | 33916271 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | CABLES2 SETD1B SCAF8 TMEM121B LMTK3 SPRED3 HNRNPL PRR12 PBRM1 FMN1 CASKIN1 TNKS PRRC2A | 1.52e-07 | 475 | 149 | 13 | 31040226 |
| Pubmed | CHERP FNBP4 EWSR1 CCNK SF1 HNRNPL PRR12 JUND RBM25 PBRM1 EIF4G1 RBM15B SMARCC2 SMN1 SCAF11 PRRC2A SF3A2 | 1.52e-07 | 847 | 149 | 17 | 35850772 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | EWSR1 SF1 HNRNPL ESRP2 MEX3A DAZAP1 EIF4G1 SCAF11 R3HDM1 PRRC2A | 1.88e-07 | 258 | 149 | 10 | 37794589 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | SHANK1 CBLL1 CHERP TCF20 RB1 MAZ IQSEC2 POU3F3 SF1 HNRNPL STRIP1 PBRM1 BRD4 EIF4G1 RBM15B SMARCC1 SMARCC2 TNKS BAG6 SF3A2 | 2.35e-07 | 1203 | 149 | 20 | 29180619 |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 2.54e-07 | 203 | 149 | 9 | 22083510 | |
| Pubmed | CHERP EWSR1 HNRNPUL1 HNRNPL SCAF4 ESRP2 RBM25 DAZAP1 SMARCC2 RPRD2 PRRC2A | 2.76e-07 | 340 | 149 | 11 | 24332808 | |
| Pubmed | FNBP4 EWSR1 HNRNPUL1 PDCD7 ZYX SETDB1 PBRM1 BRD4 EIF4G1 PPP1R9B GPNMB BAG6 SF3A2 CAP2 | 2.86e-07 | 591 | 149 | 14 | 15231748 | |
| Pubmed | 2.91e-07 | 33 | 149 | 5 | 19336002 | ||
| Pubmed | SAMD1 COL8A1 MAPKAPK2 IQSEC2 RNF19B PDCD7 HSF5 NHSL1 KMT2C TNRC18 INF2 RPRD2 TAF4 MBD5 FOXC2 | 3.09e-07 | 689 | 149 | 15 | 36543142 | |
| Pubmed | 3.27e-07 | 152 | 149 | 8 | 38360978 | ||
| Pubmed | SETD1B SCAF8 EWSR1 SF1 HNRNPL SCAF4 ESRP2 RBM25 MEX3A DAZAP1 RBM15B | 3.37e-07 | 347 | 149 | 11 | 16033648 | |
| Pubmed | COL8A1 CPSF6 EWSR1 CCNK ZYX CRK ZC3H10 SETDB1 SMARCC2 SCAF11 LTBP1 R3HDM1 PRRC2A BAG6 | 4.01e-07 | 608 | 149 | 14 | 16713569 | |
| Pubmed | REPS1 CPSF6 MAZ FNBP4 EWSR1 PDCD7 FBXO46 CCNK SF1 SCAF4 RBM25 PBRM1 DAZAP1 EIF4G1 RBM15B SMARCC1 SMARCC2 SMN1 SCAF11 WIPF2 PRRC2A | 4.37e-07 | 1371 | 149 | 21 | 36244648 | |
| Pubmed | ATF5 TCF20 POU3F3 EWSR1 RAX ZYX SF1 ZCCHC14 KMT2C JUND PBRM1 BRD4 SMARCC1 ZFHX3 FOXC2 | 4.42e-07 | 709 | 149 | 15 | 22988430 | |
| Pubmed | Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks. | 5.38e-07 | 111 | 149 | 7 | 22558309 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | BCL9L TCF20 CPSF6 SCAF8 EWSR1 RBM20 PRR12 KMT2C JUND DAZAP1 PRPF40B SMARCC1 | 7.18e-07 | 457 | 149 | 12 | 32344865 |
| Pubmed | 7.37e-07 | 17 | 149 | 4 | 14506234 | ||
| Pubmed | FBP11 regulates nuclear localization of N-WASP and inhibits N-WASP-dependent microspike formation. | 7.66e-07 | 5 | 149 | 3 | 14697212 | |
| Pubmed | 1.49e-06 | 20 | 149 | 4 | 9128241 | ||
| Pubmed | Variations in the composition of mammalian SWI/SNF chromatin remodelling complexes. | 1.53e-06 | 6 | 149 | 3 | 19650111 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 1.56e-06 | 130 | 149 | 7 | 35545047 | |
| Pubmed | ZBTB4 ARHGEF18 PTPN23 DGKD SEMA4G SCAF4 PRR12 TNRC18 MICAL3 NLGN2 MBD5 PALLD | 1.58e-06 | 493 | 149 | 12 | 15368895 | |
| Pubmed | SETD1B TCF20 SCAF8 ADGRL1 STRIP1 ZCCHC14 USP31 SETDB1 ZFR2 MICAL3 R3HDM1 | 1.60e-06 | 407 | 149 | 11 | 12693553 | |
| Pubmed | SHANK1 BCL9L EVL CPSF6 IQSEC2 MINK1 ADGRB1 ADGRL1 PANX2 NHSL1 TNRC18 ELFN1 CASKIN1 ENAH SYN2 SMARCC2 PPP1R9B BSN | 2.03e-06 | 1139 | 149 | 18 | 36417873 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | CBLL1 CHERP OTUD5 CPSF6 WASF3 EWSR1 HNRNPUL1 PNISR HNRNPL SCAF4 ZCCHC14 HOXD11 EIF4G1 SMARCC1 PRRC2A BAG6 | 2.40e-06 | 922 | 149 | 16 | 27609421 |
| Pubmed | RIAM, an Ena/VASP and Profilin ligand, interacts with Rap1-GTP and mediates Rap1-induced adhesion. | 2.66e-06 | 7 | 149 | 3 | 15469846 | |
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 2.69e-06 | 23 | 149 | 4 | 30962207 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | PRRG2 ATF5 BICRA ARHGEF18 LMTK3 CRK C6orf132 TNRC18 TNKS BSN ARAP1 | 2.72e-06 | 430 | 149 | 11 | 35044719 |
| Pubmed | SHANK1 WASL REPS1 IQSEC2 ZBTB4 EWSR1 HNRNPUL1 PDCD7 PNISR SF1 SETDB1 DAZAP1 EIF4G1 KCNN1 TNKS R3HDM1 PRRC2A SF3A2 CAP2 | 2.72e-06 | 1285 | 149 | 19 | 35914814 | |
| Pubmed | 2.79e-06 | 202 | 149 | 8 | 24639526 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | CPSF6 SCAF8 BAG3 FNBP4 PTPN23 EWSR1 HNRNPUL1 SF1 HNRNPL DAZAP1 WASF2 ENAH EIF4G1 SMARCC1 SMARCC2 SCAF11 IRS2 PRRC2A BAG6 PALLD | 2.87e-06 | 1415 | 149 | 20 | 28515276 |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | MINK1 FNBP4 DGKD SCAF4 BPTF RBM25 WASF2 ENAH ZFHX3 SCAF11 MBD5 PRRC2A | 3.73e-06 | 536 | 149 | 12 | 15840001 |
| Pubmed | MINK1 FNBP4 DGKD SCAF4 BPTF RBM25 WASF2 ENAH ZFHX3 SCAF11 MBD5 PRRC2A | 3.87e-06 | 538 | 149 | 12 | 10512203 | |
| Pubmed | CHD7 cooperates with PBAF to control multipotent neural crest formation. | 4.25e-06 | 8 | 149 | 3 | 20130577 | |
| Pubmed | 4.25e-06 | 8 | 149 | 3 | 10381382 | ||
| Pubmed | 4.25e-06 | 8 | 149 | 3 | 36335117 | ||
| Pubmed | 4.25e-06 | 8 | 149 | 3 | 28940253 | ||
| Pubmed | Interaction of WASP/Scar proteins with actin and vertebrate Arp2/3 complex. | 4.25e-06 | 8 | 149 | 3 | 11146629 | |
| Pubmed | TCF20 OTUD5 CPSF6 EWSR1 HNRNPUL1 PRR12 DAZAP1 SMARCC1 SMARCC2 SMN1 RPRD2 | 4.47e-06 | 453 | 149 | 11 | 29656893 | |
| Pubmed | 4.49e-06 | 26 | 149 | 4 | 10778858 | ||
| Pubmed | CPSF6 MAZ EWSR1 ZYX HNRNPL SCAF4 RBM25 ENAH BSN BAG6 PALLD SF3A2 WDR44 | 5.19e-06 | 653 | 149 | 13 | 33742100 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | CHERP TCF20 CPSF6 MAZ BAG3 EWSR1 HNRNPUL1 SF1 HNRNPL BPTF RBM25 DAZAP1 SMARCC1 SMARCC2 SCAF11 SF3A2 | 5.82e-06 | 989 | 149 | 16 | 36424410 |
| Pubmed | 6.35e-06 | 9 | 149 | 3 | 8861907 | ||
| Pubmed | 6.35e-06 | 9 | 149 | 3 | 11044623 | ||
| Pubmed | 6.62e-06 | 61 | 149 | 5 | 20305087 | ||
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 7.01e-06 | 163 | 149 | 7 | 22113938 | |
| Pubmed | 7.07e-06 | 29 | 149 | 4 | 19279220 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 8.21e-06 | 167 | 149 | 7 | 20362541 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CHERP TCF20 CPSF6 EWSR1 HNRNPUL1 SF1 HNRNPL SCAF4 BPTF RBM25 PBRM1 DAZAP1 EIF4G1 SMARCC2 BAG6 SF3A2 | 8.97e-06 | 1024 | 149 | 16 | 24711643 |
| Pubmed | FBP WW domains and the Abl SH3 domain bind to a specific class of proline-rich ligands. | 9.05e-06 | 10 | 149 | 3 | 9171351 | |
| Pubmed | 1.02e-05 | 114 | 149 | 6 | 31553912 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | EVL CPSF6 MAPKAPK2 IQSEC2 PNISR ZYX SETDB1 ENAH SIK2 SMN1 RPRD2 TNKS IRS2 MAPK7 R3HDM1 DMWD | 1.06e-05 | 1038 | 149 | 16 | 26673895 |
| Pubmed | CDX1 TCF20 HNRNPUL1 RAX ZYX SF1 ZCCHC14 ZC3H10 BPTF PBRM1 BRD4 SMARCC1 SMN1 ZFHX3 | 1.08e-05 | 808 | 149 | 14 | 20412781 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | EVL FNBP4 EWSR1 HNRNPUL1 PDCD7 PNISR CCNK WASF2 RBM15B SMARCC1 SMARCC2 PPP1R9B PRRC2A | 1.10e-05 | 701 | 149 | 13 | 30196744 |
| Pubmed | MAZ MINK1 BAG3 PTPN23 ZYX RBM20 HNRNPL USP31 NHSL1 ENAH PPP1R9B MICAL3 LTBP1 DMWD PRRC2A CAP2 | 1.21e-05 | 1049 | 149 | 16 | 27880917 | |
| Pubmed | SRF is essential for mesodermal cell migration during elongation of the embryonic body axis. | 1.24e-05 | 11 | 149 | 3 | 25020278 | |
| Pubmed | 1.24e-05 | 118 | 149 | 6 | 16971476 | ||
| Pubmed | SHANK1 EVL WASL IQSEC2 MINK1 ADGRL1 EWSR1 STRIP1 USP31 NHSL1 INF2 CASKIN1 EIF4G1 SYN2 SMARCC2 PPP1R9B MICAL3 BSN PRRC2A | 1.25e-05 | 1431 | 149 | 19 | 37142655 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | CHERP FNBP4 EWSR1 HNRNPL RBM25 PBRM1 EIF4G1 RBM15B SMARCC1 SMARCC2 ZFHX3 SCAF11 | 1.26e-05 | 605 | 149 | 12 | 28977666 |
| Pubmed | C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways. | 1.30e-05 | 119 | 149 | 6 | 35776542 | |
| Pubmed | 1.30e-05 | 119 | 149 | 6 | 23508102 | ||
| Interaction | PRPF40A interactions | EVL WASL CHERP CPSF6 MAPKAPK2 WASF3 FNBP4 EWSR1 HNRNPUL1 PDCD7 AR SF1 SCAF4 ZC3H10 RBM25 FMN1 WASF2 BRD4 ENAH SMARCC1 SMARCC2 ZFHX3 BAG6 SF3A2 APBB1IP CAP2 | 2.88e-16 | 446 | 149 | 26 | int:PRPF40A |
| Interaction | PRMT2 interactions | SHANK1 ESPN SAMD1 WASL SETD1B RB1 IQSEC2 HNRNPUL1 SF1 DAZAP1 R3HDM1 PRRC2A BAG6 | 1.36e-13 | 91 | 149 | 13 | int:PRMT2 |
| Interaction | SNRNP40 interactions | CBLL1 ESPN BCL9L CHERP TCF20 CPSF6 SCAF8 ZBTB4 EWSR1 HNRNPUL1 PNISR RBM20 HNRNPL SCAF4 RBM25 DAZAP1 PRPF40B BRD4 SMARCC1 SMARCC2 ZFHX3 SCAF11 TAF4 SF3A2 | 5.17e-11 | 637 | 149 | 24 | int:SNRNP40 |
| Interaction | TLE3 interactions | CBLL1 BCL9L CHERP TCF20 SCAF8 ZBTB4 AR RBM20 HNRNPL SCAF4 PRR12 JUND TNRC18 PRPF40B BRD4 SMARCC2 ZFHX3 TAF4 | 3.80e-10 | 376 | 149 | 18 | int:TLE3 |
| Interaction | FMR1 interactions | CBLL1 CDX1 TBKBP1 TCF20 IQSEC2 BAG3 ARHGEF18 DGKD EWSR1 LMTK3 HNRNPL PBRM1 MEX3A DAZAP1 CASKIN1 BRD4 EIF4G1 SMARCC2 R3HDM1 BSN PRRC2A | 4.64e-10 | 536 | 149 | 21 | int:FMR1 |
| Interaction | ACTC1 interactions | WASL CHERP CPSF6 BICRA FNBP4 PNISR CCNK ZYX SF1 SCAF4 RBM25 INF2 WASF2 BRD4 ENAH SMARCC1 SMARCC2 PPP1R9B RPRD2 WIPF2 SF3A2 CAP2 KLHL17 | 1.64e-09 | 694 | 149 | 23 | int:ACTC1 |
| Interaction | EWSR1 interactions | BCL9L CHERP TCF20 CPSF6 BICRA MAPK1IP1L MAZ BAG3 FNBP4 POU3F3 EWSR1 HNRNPUL1 PNISR SF1 HNRNPL PRR12 DAZAP1 BRD4 PRR13 SMARCC1 SMARCC2 SMN1 TAF4 R3HDM1 PRRC2A BAG6 | 2.62e-09 | 906 | 149 | 26 | int:EWSR1 |
| Interaction | BAIAP2 interactions | SHANK1 ESPN EVL WASL ADGRB1 HNRNPL C6orf132 WASF2 BRD4 PRR13 ENAH PPP1R9B SF3A2 | 3.34e-09 | 201 | 149 | 13 | int:BAIAP2 |
| Interaction | YAP1 interactions | PRRG2 BCL9L WASL REPS1 TCF20 RB1 CPSF6 BAG3 FNBP4 POU3F2 HNRNPUL1 CCNK AR ZYX CRK SCAF4 BPTF KMT2C TNRC18 RBM25 BRD4 ENAH SMARCC1 SMARCC2 RPRD2 TAF4 PRRC2A PALLD | 7.43e-09 | 1095 | 149 | 28 | int:YAP1 |
| Interaction | NCK2 interactions | WASL CPSF6 MINK1 WASF3 SCX SF1 HNRNPL NHSL1 WASF2 SIK2 WIPF2 PRRC2A SF3A2 ARAP1 | 9.49e-09 | 262 | 149 | 14 | int:NCK2 |
| Interaction | SOX7 interactions | 9.58e-09 | 82 | 149 | 9 | int:SOX7 | |
| Interaction | FUBP1 interactions | MAPK1IP1L HNRNPUL1 AR CRK HNRNPL RBM25 DAZAP1 PRPF40B BRD4 PRR13 EIF4G1 SMARCC1 SMARCC2 SMN1 SF3A2 | 1.00e-08 | 309 | 149 | 15 | int:FUBP1 |
| Interaction | ALG13 interactions | TCF20 CPSF6 SCAF8 CCNK ZYX RBM20 SF1 PRR12 ZC3H10 RBM25 R3HDM1 PRRC2A | 1.18e-08 | 183 | 149 | 12 | int:ALG13 |
| Interaction | SMC5 interactions | CBLL1 CHERP TCF20 CPSF6 BICRA MAZ FNBP4 EWSR1 HNRNPUL1 CCNK SF1 HNRNPL SCAF4 BPTF RBM25 DAZAP1 BRD4 EIF4G1 RBM15B SMARCC1 SMARCC2 SMN1 RPRD2 SCAF11 TAF4 PRRC2A | 1.99e-08 | 1000 | 149 | 26 | int:SMC5 |
| Interaction | TOP3B interactions | TBKBP1 SETD1B REPS1 ZNF628 MAPKAPK2 BICRA RNPEPL1 ZBTB4 ADGRL1 FBXO46 C6orf132 ESRP2 ZCCHC14 PRR12 NHSL1 KMT2C HOXB4 JUND TNRC18 INF2 CASKIN1 BRD4 EIF4G1 PPP1R9B MICAL3 NLGN2 IRS2 MBD5 DMWD PRRC2A ARAP1 KLHL17 | 2.50e-08 | 1470 | 149 | 32 | int:TOP3B |
| Interaction | CEBPA interactions | EVL CDX1 ATF5 TCF20 RB1 CPSF6 BICRA EWSR1 HNRNPUL1 CCNK AR ZYX SF1 HNRNPL SCAF4 PRR12 ZC3H10 BPTF KMT2C JUND TNRC18 DAZAP1 BRD4 SMARCC1 SMARCC2 TAF4 PRRC2A BAG6 SF3A2 | 3.01e-08 | 1245 | 149 | 29 | int:CEBPA |
| Interaction | CELF1 interactions | CPSF6 SCAF8 EWSR1 HNRNPUL1 RBM20 SF1 HNRNPL SCAF4 ESRP2 MEX3A DAZAP1 BRD4 R3HDM1 PRRC2A | 3.13e-08 | 288 | 149 | 14 | int:CELF1 |
| Interaction | BICRA interactions | 3.33e-08 | 67 | 149 | 8 | int:BICRA | |
| Interaction | VASP interactions | EVL REPS1 BAG3 PTPN23 ZYX C6orf132 NHSL1 INF2 WASF2 ENAH PPP1R9B IRS2 PALLD APBB1IP | 4.05e-08 | 294 | 149 | 14 | int:VASP |
| Interaction | POU5F1 interactions | TCF20 CPSF6 SCAF8 POU3F3 EWSR1 PDCD7 AR HNRNPL BPTF SETDB1 PBRM1 BRD4 PCDH15 SMARCC1 SMARCC2 ZFHX3 SCAF11 BAG6 SF3A2 | 6.56e-08 | 584 | 149 | 19 | int:POU5F1 |
| Interaction | WBP4 interactions | 1.18e-07 | 109 | 149 | 9 | int:WBP4 | |
| Interaction | NFIX interactions | RB1 BICRA AR HNRNPL PRR12 BPTF KMT2C PBRM1 SMARCC1 SMARCC2 ZFHX3 TAF4 | 1.27e-07 | 227 | 149 | 12 | int:NFIX |
| Interaction | EVL interactions | 1.83e-07 | 83 | 149 | 8 | int:EVL | |
| Interaction | ACTG1 interactions | EVL WASL TBKBP1 CPSF6 WASF3 INF2 WASF2 BRD4 ENAH SMARCC1 SMARCC2 PPP1R9B MAPK7 WIPF2 CAP2 WDR44 KLHL17 | 3.18e-07 | 520 | 149 | 17 | int:ACTG1 |
| Interaction | CPSF6 interactions | CBLL1 CPSF6 BAG3 EWSR1 HNRNPUL1 AR HNRNPL SCAF4 RBM25 BRD4 EIF4G1 SMARCC1 SMARCC2 SMN1 RPRD2 SCAF11 SF3A2 | 3.73e-07 | 526 | 149 | 17 | int:CPSF6 |
| Interaction | SP7 interactions | BCL9L TCF20 SCAF8 BICRA RBM20 SCAF4 PRR12 KMT2C RBM25 PBRM1 SMARCC1 SMARCC2 RPRD2 | 4.33e-07 | 304 | 149 | 13 | int:SP7 |
| Interaction | BCHE interactions | 5.10e-07 | 65 | 149 | 7 | int:BCHE | |
| Interaction | ATXN1 interactions | ATF5 OTUD5 CPSF6 BAG3 PTPN23 PANX2 CCNK AR ZYX SF1 SEMA4G CRK HNRNPL STRIP1 ZC3H10 RBM25 DAZAP1 BRD4 EIF4G1 SMARCC2 R3HDM1 PRRC2A BAG6 SF3A2 | 6.49e-07 | 1039 | 149 | 24 | int:ATXN1 |
| Interaction | ARHGAP12 interactions | 6.97e-07 | 68 | 149 | 7 | int:ARHGAP12 | |
| Interaction | BAG2 interactions | TCF20 OTUD5 MAPKAPK2 BAG3 FNBP4 PTPN23 SF1 ESRP2 BPTF RBM25 BRD4 ENAH SIK2 RPRD2 MAPK7 R3HDM1 PALLD SF3A2 | 8.26e-07 | 622 | 149 | 18 | int:BAG2 |
| Interaction | AR interactions | BCL9L CHERP TCF20 RB1 CPSF6 POU3F3 HNRNPUL1 CCNK AR CRK HNRNPL PRR12 KMT2C TNRC18 RBM25 PBRM1 DAZAP1 BRD4 SMARCC1 SMARCC2 ZFHX3 RPRD2 BAG6 | 1.07e-06 | 992 | 149 | 23 | int:AR |
| Interaction | DTX2 interactions | BCL9L CHERP TCF20 CPSF6 SCAF8 EWSR1 SF1 ESRP2 PRR12 HOXB2 EIF4G1 RPRD2 R3HDM1 | 1.09e-06 | 330 | 149 | 13 | int:DTX2 |
| Interaction | PFN1 interactions | EVL WASL CPSF6 BAG3 AR C6orf132 NHSL1 DAZAP1 INF2 WASF2 ENAH MICAL3 WIPF2 PALLD APBB1IP WDR44 | 1.21e-06 | 509 | 149 | 16 | int:PFN1 |
| Interaction | DAZL interactions | 1.34e-06 | 145 | 149 | 9 | int:DAZL | |
| Interaction | ACTB interactions | WASL WASF3 BAG3 AR ZYX CRK HNRNPL C6orf132 NHSL1 PBRM1 INF2 WASF2 ENAH SIK2 SYN2 SMARCC1 SMARCC2 PPP1R9B SMN1 MAPK7 WIPF2 PALLD CAP2 WDR44 | 1.35e-06 | 1083 | 149 | 24 | int:ACTB |
| Interaction | DHX8 interactions | CDX1 CHERP TCF20 CPSF6 MAPKAPK2 BAG3 FNBP4 PNISR CCNK RBM25 RPRD2 SCAF11 | 1.86e-06 | 292 | 149 | 12 | int:DHX8 |
| Interaction | MEN1 interactions | SAMD1 COL8A1 CHERP SETD1B TCF20 CPSF6 FNBP4 EWSR1 CCNK SF1 CRK PRR12 BPTF KMT2C JUND RBM25 PBRM1 EIF4G1 SMARCC2 SMN1 SCAF11 PRRC2A SF3A2 | 2.00e-06 | 1029 | 149 | 23 | int:MEN1 |
| Interaction | WWTR1 interactions | PRRG2 TCF20 RB1 BAG3 PTPN23 ZYX BPTF RBM25 BRD4 ENAH SMARCC1 RPRD2 PRRC2A WDR44 | 3.13e-06 | 422 | 149 | 14 | int:WWTR1 |
| Interaction | TCERG1 interactions | 3.32e-06 | 207 | 149 | 10 | int:TCERG1 | |
| Interaction | PAX6 interactions | RB1 BICRA INSM1 RAX AR PRR12 BPTF KMT2C HOXB4 PBRM1 SMARCC1 SMARCC2 ZFHX3 | 3.42e-06 | 366 | 149 | 13 | int:PAX6 |
| Interaction | DDX17 interactions | CBLL1 CPSF6 FNBP4 EWSR1 HNRNPUL1 AR SF1 HNRNPL MEX3A BRD4 SMARCC2 SMN1 MBD5 SF3A2 | 3.49e-06 | 426 | 149 | 14 | int:DDX17 |
| Interaction | SH3YL1 interactions | 3.68e-06 | 15 | 149 | 4 | int:SH3YL1 | |
| Interaction | ABL1 interactions | 3.69e-06 | 259 | 149 | 11 | int:ABL1 | |
| Interaction | EP300 interactions | ATF5 RB1 CPSF6 MAZ POU3F2 EWSR1 HNRNPUL1 AR ZYX SF1 HNRNPL SCAF4 HOXB2 HOXB4 JUND RBM25 MEX3A BRD4 ENAH SIK2 SMARCC1 SMARCC2 BSN BAG6 PALLD SF3A2 WDR44 | 3.89e-06 | 1401 | 149 | 27 | int:EP300 |
| Interaction | YWHAZ interactions | EVL MAPKAPK2 IQSEC2 MINK1 WASF3 BAG3 ARHGEF18 EWSR1 HNRNPUL1 AR CRK HNRNPL C6orf132 USP31 NHSL1 BRD4 ENAH SIK2 SYN2 PPP1R9B SCAF11 IRS2 MAPK7 R3HDM1 DMWD PRRC2A | 4.04e-06 | 1319 | 149 | 26 | int:YWHAZ |
| Interaction | HSPA2 interactions | OTUD5 BAG3 FNBP4 PTPN23 EWSR1 SF1 INF2 BRD4 SIK2 PPP1R9B RPRD2 BAG6 PALLD SF3A2 | 5.06e-06 | 440 | 149 | 14 | int:HSPA2 |
| Interaction | YWHAE interactions | IQSEC2 MINK1 WASF3 BAG3 EWSR1 HNRNPUL1 ZYX CRK HNRNPL C6orf132 USP31 BRD4 SIK2 SYN2 SMARCC2 PPP1R9B SCAF11 LTBP1 IRS2 TAF4 MAPK7 R3HDM1 DMWD PRRC2A CAP2 | 5.37e-06 | 1256 | 149 | 25 | int:YWHAE |
| Interaction | PAX9 interactions | 5.61e-06 | 130 | 149 | 8 | int:PAX9 | |
| Interaction | SUZ12 interactions | CBLL1 BCL9L CPSF6 EWSR1 AR SF1 BPTF SETDB1 PBRM1 DAZAP1 BRD4 RBM15B SMARCC1 SMARCC2 PPP1R9B SCAF11 BAG6 | 5.82e-06 | 644 | 149 | 17 | int:SUZ12 |
| Interaction | YWHAH interactions | TCF20 MAZ IQSEC2 MINK1 BAG3 PLEKHG2 HNRNPUL1 CRK C6orf132 ZCCHC14 USP31 NHSL1 WASF2 BRD4 EIF4G1 RBM15B SIK2 PPP1R9B IRS2 MAPK7 R3HDM1 DMWD PALLD | 6.24e-06 | 1102 | 149 | 23 | int:YWHAH |
| Interaction | ERG interactions | TCF20 BICRA HNRNPUL1 AR PRR12 KMT2C SETDB1 BRD4 SMARCC1 SMARCC2 | 6.43e-06 | 223 | 149 | 10 | int:ERG |
| Interaction | SNRPB interactions | CHERP CPSF6 MINK1 FNBP4 EWSR1 PDCD7 HNRNPL SCAF4 RBM25 BRD4 SMN1 RPRD2 MICAL3 SCAF11 SF3A2 | 6.99e-06 | 517 | 149 | 15 | int:SNRPB |
| Interaction | H3C6 interactions | CHERP SETD1B HNRNPL RBM25 PBRM1 SMARCC1 SMARCC2 TAF4 PRRC2A SF3A2 | 7.23e-06 | 226 | 149 | 10 | int:H3C6 |
| Interaction | SOX9 interactions | 7.72e-06 | 97 | 149 | 7 | int:SOX9 | |
| Interaction | MECP2 interactions | CBLL1 CHERP TCF20 CPSF6 MAZ FNBP4 EWSR1 HNRNPUL1 LMTK3 PDCD7 PNISR CCNK SF1 HNRNPL SCAF4 BPTF RBM25 PRPF40B BRD4 EIF4G1 PCDH15 RBM15B SMARCC1 SMARCC2 SF3A2 | 8.20e-06 | 1287 | 149 | 25 | int:MECP2 |
| Interaction | KDM5B interactions | 9.45e-06 | 100 | 149 | 7 | int:KDM5B | |
| Interaction | CCAR1 interactions | 1.07e-05 | 187 | 149 | 9 | int:CCAR1 | |
| Interaction | TAF15 interactions | CHERP CPSF6 EWSR1 HNRNPUL1 AR SF1 HNRNPL RBM25 BRD4 SMARCC1 SMARCC2 SCAF11 TAF4 | 1.10e-05 | 408 | 149 | 13 | int:TAF15 |
| Interaction | FXR1 interactions | SHANK1 EVL SAMD1 REPS1 CPSF6 HNRNPUL1 LMTK3 AR DAZAP1 BRD4 PRR13 EIF4G1 KCNN1 SMARCC2 MAPK7 R3HDM1 PRRC2A | 1.16e-05 | 679 | 149 | 17 | int:FXR1 |
| Interaction | FUS interactions | CHERP CPSF6 EWSR1 HNRNPUL1 SF1 HNRNPL SCAF4 ESRP2 RBM25 PBRM1 BRD4 SIK2 SMARCC1 SMARCC2 SMN1 RPRD2 PRRC2A SF3A2 | 1.27e-05 | 757 | 149 | 18 | int:FUS |
| Interaction | WASF2 interactions | 1.32e-05 | 146 | 149 | 8 | int:WASF2 | |
| Interaction | FUBP3 interactions | CPSF6 HNRNPUL1 AR RBM20 SF1 MEX3A DAZAP1 BRD4 SMARCC1 R3HDM1 PRRC2A | 1.35e-05 | 297 | 149 | 11 | int:FUBP3 |
| Interaction | EYA4 interactions | CPSF6 BICRA MAPK1IP1L BAG3 EWSR1 CCNK SF1 PRR12 DAZAP1 R3HDM1 | 1.36e-05 | 243 | 149 | 10 | int:EYA4 |
| Interaction | ITSN2 interactions | 1.39e-05 | 147 | 149 | 8 | int:ITSN2 | |
| Interaction | SNRPA interactions | EWSR1 HNRNPUL1 SF1 HNRNPL SCAF4 ZC3H10 RBM25 DAZAP1 BRD4 SMN1 RPRD2 SCAF11 MAPK7 SF3A2 | 1.42e-05 | 482 | 149 | 14 | int:SNRPA |
| Interaction | APBB1 interactions | 1.50e-05 | 195 | 149 | 9 | int:APBB1 | |
| Interaction | POU3F3 interactions | 1.89e-05 | 22 | 149 | 4 | int:POU3F3 | |
| Interaction | CRX interactions | BCL9L TCF20 BICRA PRR12 ZC3H10 KMT2C TNRC18 PBRM1 SMARCC1 ZFHX3 | 2.00e-05 | 254 | 149 | 10 | int:CRX |
| Interaction | WASF1 interactions | 2.49e-05 | 116 | 149 | 7 | int:WASF1 | |
| Interaction | SMG7 interactions | TCF20 CPSF6 SCAF8 HNRNPUL1 ZYX RBM20 HNRNPL PRR12 RPRD2 R3HDM1 PRRC2A | 2.61e-05 | 319 | 149 | 11 | int:SMG7 |
| Interaction | GLDC interactions | CHERP TCF20 EWSR1 HNRNPUL1 HNRNPL EIF4G1 SMARCC1 SMARCC2 PPP1R9B R3HDM1 PRRC2A | 2.76e-05 | 321 | 149 | 11 | int:GLDC |
| Interaction | GRB2 interactions | WASL REPS1 RB1 OTUD5 CPSF6 MINK1 BAG3 PTPN23 HCN2 AR CRK WASF2 IRS2 WIPF2 PRRC2A SF3A2 ARAP1 WDR44 | 2.91e-05 | 806 | 149 | 18 | int:GRB2 |
| Interaction | BARD1 interactions | CPSF6 EWSR1 HNRNPUL1 CCNK HNRNPL SCAF4 SETDB1 RBM25 MICAL3 SCAF11 TNKS | 2.93e-05 | 323 | 149 | 11 | int:BARD1 |
| Interaction | MED23 interactions | 2.96e-05 | 266 | 149 | 10 | int:MED23 | |
| Interaction | DOT1L interactions | CHERP FNBP4 CCNK AR SF1 HNRNPL JUND RBM25 PBRM1 EIF4G1 RBM15B SMARCC2 SMN1 SCAF11 MAPK7 PRRC2A BAG6 SF3A2 | 2.96e-05 | 807 | 149 | 18 | int:DOT1L |
| Interaction | APBB1IP interactions | 3.22e-05 | 25 | 149 | 4 | int:APBB1IP | |
| Interaction | ETS1 interactions | 3.28e-05 | 121 | 149 | 7 | int:ETS1 | |
| Interaction | NCKAP1 interactions | 3.62e-05 | 218 | 149 | 9 | int:NCKAP1 | |
| Interaction | HDAC4 interactions | CABLES2 SETD1B CPSF6 SCAF8 TMEM121B LMTK3 AR SF1 SPRED3 HNRNPL PRR12 PBRM1 FMN1 WASF2 CASKIN1 TNKS PRRC2A | 3.71e-05 | 744 | 149 | 17 | int:HDAC4 |
| Interaction | HNF4A interactions | 3.93e-05 | 275 | 149 | 10 | int:HNF4A | |
| Interaction | EGR2 interactions | 4.11e-05 | 171 | 149 | 8 | int:EGR2 | |
| Interaction | ABI1 interactions | 4.32e-05 | 223 | 149 | 9 | int:ABI1 | |
| Interaction | YWHAG interactions | WASL MAZ IQSEC2 MINK1 BAG3 EWSR1 PLEKHG2 HNRNPUL1 CRK C6orf132 USP31 NHSL1 WASF2 EIF4G1 RBM15B SIK2 SYN2 PPP1R9B SCAF11 IRS2 MAPK7 R3HDM1 DMWD | 4.50e-05 | 1248 | 149 | 23 | int:YWHAG |
| Interaction | PRRG2 interactions | 4.58e-05 | 10 | 149 | 3 | int:PRRG2 | |
| Interaction | JUN interactions | TCF20 RB1 MAZ EWSR1 AR KMT2C JUND MEX3A BRD4 SMARCC1 SMARCC2 TAF4 PRRC2A | 4.81e-05 | 470 | 149 | 13 | int:JUN |
| Interaction | RBBP5 interactions | 5.62e-05 | 287 | 149 | 10 | int:RBBP5 | |
| Interaction | YWHAB interactions | CPSF6 IQSEC2 MINK1 WASF3 BAG3 HNRNPUL1 ZYX CRK C6orf132 USP31 NHSL1 WASF2 EIF4G1 SIK2 SYN2 PPP1R9B IRS2 MAPK7 R3HDM1 DMWD | 5.91e-05 | 1014 | 149 | 20 | int:YWHAB |
| Interaction | HDLBP interactions | REPS1 CPSF6 MAZ EWSR1 FBXO46 CCNK ZYX SF1 SCAF4 RBM25 DAZAP1 EIF4G1 RBM15B SMARCC1 SMARCC2 SMN1 WIPF2 PRRC2A | 6.26e-05 | 855 | 149 | 18 | int:HDLBP |
| Interaction | WWOX interactions | WASL CPSF6 SCAF8 SMR3A HNRNPUL1 PDCD7 HNRNPL SCAF4 DAZAP1 ENAH SMARCC1 RPRD2 WIPF2 PRRC2A SF3A2 | 6.54e-05 | 627 | 149 | 15 | int:WWOX |
| Interaction | HDAC2 interactions | TCF20 RB1 BAG3 PDX1 EWSR1 AR ZYX SF1 BPTF SETDB1 INF2 BRD4 SMARCC1 SMARCC2 SMN1 RPRD2 LTBP1 FOXC2 | 7.26e-05 | 865 | 149 | 18 | int:HDAC2 |
| Interaction | NUP35 interactions | BCL9L TCF20 CPSF6 SCAF8 EWSR1 RBM20 PRR12 KMT2C JUND DAZAP1 PRPF40B SMARCC1 | 7.62e-05 | 424 | 149 | 12 | int:NUP35 |
| Interaction | P4HA1 interactions | 7.69e-05 | 298 | 149 | 10 | int:P4HA1 | |
| Interaction | UBAP2L interactions | CPSF6 BAG3 EWSR1 AR HNRNPL ESRP2 ZCCHC14 MEX3A R3HDM1 PRRC2A | 7.69e-05 | 298 | 149 | 10 | int:UBAP2L |
| Interaction | ATN1 interactions | 7.73e-05 | 187 | 149 | 8 | int:ATN1 | |
| Interaction | RNPS1 interactions | CHERP REPS1 CPSF6 BICRA PNISR CCNK AR SCAF4 RBM25 TAF4 SF3A2 WDR44 | 7.80e-05 | 425 | 149 | 12 | int:RNPS1 |
| Interaction | SHANK3 interactions | SHANK1 BCL9L TBKBP1 TCF20 IQSEC2 ADGRL1 LMTK3 HCN2 WASF2 CASKIN1 PPP1R9B ZFHX3 NLGN2 | 8.29e-05 | 496 | 149 | 13 | int:SHANK3 |
| Interaction | DDX5 interactions | CBLL1 CPSF6 MAPKAPK2 EWSR1 HNRNPUL1 FBXO46 AR CRK HNRNPL BRD4 PPP1R9B SMN1 MBD5 SF3A2 | 8.45e-05 | 568 | 149 | 14 | int:DDX5 |
| Interaction | HNF1B interactions | 8.64e-05 | 190 | 149 | 8 | int:HNF1B | |
| Interaction | CAPZB interactions | REPS1 MINK1 WASF3 BAG3 ARHGEF18 EWSR1 AR SF1 CRK JUND INF2 ENAH EIF4G1 SYN2 SMARCC1 PPP1R9B DMWD PRRC2A CAP2 ARAP1 | 9.41e-05 | 1049 | 149 | 20 | int:CAPZB |
| Interaction | MSX2 interactions | 1.04e-04 | 195 | 149 | 8 | int:MSX2 | |
| Cytoband | 19q13.3 | 7.51e-06 | 82 | 149 | 5 | 19q13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | SHANK1 IL11 PRRG2 ATF5 ZNF628 BICRA PLEKHG2 HNRNPUL1 LMTK3 FBXO46 SPRED3 HNRNPL PRR12 MZF1 DMWD | 8.61e-06 | 1192 | 149 | 15 | chr19q13 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | SAMD1 CHERP ARHGEF18 ADGRL1 HCN2 JUND DAZAP1 ZFR2 BRD4 KCNN1 LYL1 SF3A2 | 1.25e-05 | 797 | 149 | 12 | chr19p13 |
| Cytoband | 19p13.1 | 5.21e-04 | 48 | 149 | 3 | 19p13.1 | |
| Cytoband | 17q21.32 | 5.53e-04 | 49 | 149 | 3 | 17q21.32 | |
| Cytoband | 19p13.3 | 1.10e-03 | 237 | 149 | 5 | 19p13.3 | |
| GeneFamily | RNA binding motif containing | SETD1B CPSF6 SCAF8 EWSR1 RBM20 HNRNPL SCAF4 ESRP2 RBM25 DAZAP1 RBM15B | 5.95e-08 | 213 | 108 | 11 | 725 |
| GeneFamily | Sterile alpha motif domain containing | 9.51e-07 | 88 | 108 | 7 | 760 | |
| GeneFamily | HOXL subclass homeoboxes | 1.44e-05 | 52 | 108 | 5 | 518 | |
| GeneFamily | ENAH/VASPs | 1.06e-04 | 3 | 108 | 2 | 946 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 1.10e-04 | 16 | 108 | 3 | 14 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.37e-04 | 206 | 108 | 7 | 682 | |
| GeneFamily | BCL2 associated athanogene family | 5.22e-04 | 6 | 108 | 2 | 1139 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.08e-03 | 34 | 108 | 3 | 487 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 1.88e-03 | 11 | 108 | 2 | 1025 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 6.26e-03 | 20 | 108 | 2 | 1371 | |
| Coexpression | GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN | ATF5 SETD1B TCF20 TMEM121B JUND PRR13 PPP1R9B LYL1 APBB1IP ARAP1 WDR44 | 1.93e-08 | 198 | 149 | 11 | M5861 |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_NEURON_AGEING | PRRG2 BCL9L EVL MAZ IQSEC2 MINK1 ADGRB1 ADGRL1 PANX2 HCN2 PNISR ZYX SEMA4G ZCCHC14 USP31 JUND INF2 PRR13 PPP1R9B LTBP1 BSN SF3A2 | 2.44e-08 | 954 | 149 | 22 | MM3689 |
| Coexpression | GSE37532_WT_VS_PPARG_KO_LN_TREG_UP | 7.88e-07 | 176 | 149 | 9 | M8952 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | BCL9L COL8A1 MAPK1IP1L BAG3 EWSR1 ZYX BPTF JUND RBM25 BRD4 PRR13 EIF4G1 ZFHX3 LTBP1 PALLD APBB1IP | 1.94e-06 | 685 | 149 | 16 | MM3782 |
| Coexpression | GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN | 2.18e-06 | 199 | 149 | 9 | M5874 | |
| Coexpression | GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP | 2.27e-06 | 200 | 149 | 9 | M7060 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 2.90e-06 | 206 | 149 | 9 | M2817 | |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_DN | 3.07e-06 | 155 | 149 | 8 | M8944 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 3.14e-06 | 208 | 149 | 9 | MM581 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | ATF5 BICRA MINK1 FNBP4 FBXO46 SF1 SETDB1 DAZAP1 RBM15B DMWD PRRC2A | 3.95e-06 | 338 | 149 | 11 | M17094 |
| Coexpression | GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_UP | 9.25e-06 | 180 | 149 | 8 | M357 | |
| Coexpression | GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_DN | 1.78e-05 | 197 | 149 | 8 | M5879 | |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 1.91e-05 | 199 | 149 | 8 | M7254 | |
| Coexpression | GSE17721_CTRL_VS_LPS_6H_BMDC_DN | 1.91e-05 | 199 | 149 | 8 | M3692 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K27ME3 | IL11 ADGRB1 PDX1 HCN2 C6orf132 HOXB2 HOXB4 HOXD11 PGBD5 HRH3 | 2.97e-05 | 345 | 149 | 10 | M2009 |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K27ME3 | IL11 ADGRB1 PDX1 HCN2 C6orf132 HOXB2 HOXB4 HOXD11 PGBD5 HRH3 | 3.12e-05 | 347 | 149 | 10 | MM860 |
| Coexpression | GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP | 4.75e-05 | 166 | 149 | 7 | M344 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MATURE_ALPHA_BETA_T_CELL_AGEING | BCL9L EVL BICRA HNRNPUL1 HNRNPL JUND DAZAP1 BRD4 PRR13 RBM15B R3HDM1 BAG6 APBB1IP | 4.97e-05 | 612 | 149 | 13 | MM3804 |
| Coexpression | GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_UP | 5.73e-05 | 171 | 149 | 7 | M8594 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | CBLL1 IL11 TCF20 RNF19B BAG3 FNBP4 PNISR ZCCHC14 JUND RBM25 BRD4 IRS2 MAPK7 WIPF2 PALLD | 7.29e-05 | 822 | 149 | 15 | M6782 |
| Coexpression | TABULA_MURIS_SENIS_LARGE_INTESTINE_SECRETORY_CELL_AGEING | PRRG2 CDX1 CPSF6 MAZ BAG3 EWSR1 SF1 JUND RBM25 PRR13 EIF4G1 ZFHX3 SMPD1 BSN | 8.05e-05 | 734 | 149 | 14 | MM3740 |
| Coexpression | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN | 9.09e-05 | 184 | 149 | 7 | M19988 | |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_UP | 1.07e-04 | 189 | 149 | 7 | M9978 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN | 1.39e-04 | 197 | 149 | 7 | M5853 | |
| Coexpression | GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_UP | 1.43e-04 | 198 | 149 | 7 | M3108 | |
| Coexpression | GSE35543_IN_VIVO_NTREG_VS_IN_VITRO_ITREG_UP | 1.48e-04 | 199 | 149 | 7 | M9430 | |
| Coexpression | GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN | 1.48e-04 | 199 | 149 | 7 | M7607 | |
| Coexpression | GSE17721_CTRL_VS_CPG_12H_BMDC_DN | 1.48e-04 | 199 | 149 | 7 | M3770 | |
| Coexpression | GSE11924_TFH_VS_TH1_CD4_TCELL_UP | 1.48e-04 | 199 | 149 | 7 | M3151 | |
| Coexpression | GSE27786_NKCELL_VS_ERYTHROBLAST_DN | 1.52e-04 | 200 | 149 | 7 | M4854 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_UP | 1.52e-04 | 200 | 149 | 7 | M4016 | |
| Coexpression | GSE28237_EARLY_VS_LATE_GC_BCELL_DN | 1.52e-04 | 200 | 149 | 7 | M4894 | |
| Coexpression | GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN | 1.52e-04 | 200 | 149 | 7 | M9260 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 2.42e-04 | 363 | 149 | 9 | M41103 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000 | WASL REPS1 CPSF6 PNISR AR RBM20 SEMA4G USP31 HOXB2 HOXB4 RPRD2 TNKS LTBP1 TAF4 MBD5 CAP2 FOXC2 | 3.16e-05 | 779 | 148 | 17 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000 |
| CoexpressionAtlas | cerebral cortex | SHANK1 PSD WASF3 ADGRB1 ADGRL1 POU3F2 POU3F3 PANX2 LMTK3 HCN2 SPRED3 EGR4 ELFN1 ZFR2 CASKIN1 MANEAL PCDH15 KCNN1 SYN2 NLGN2 BSN PGBD5 CAP2 HRH3 | 5.10e-05 | 1428 | 148 | 24 | cerebral cortex |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | CBLL1 REPS1 RB1 INSM1 POU3F3 EWSR1 HNRNPUL1 PDCD7 PNISR CRK BPTF MANEAL ENAH RPRD2 | 7.42e-05 | 595 | 148 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | CBLL1 INSM1 POU3F3 EWSR1 SF1 CRK SETDB1 RBM25 MEX3A EIF4G1 SMARCC1 SMN1 ZFHX3 PRRC2A BAG6 SF3A2 FOXC2 | 8.37e-05 | 843 | 148 | 17 | gudmap_developingGonad_e11.5_testes_1000 |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.40e-09 | 178 | 149 | 9 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-07 | 186 | 149 | 8 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-07 | 188 | 149 | 8 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-07 | 189 | 149 | 8 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.86e-07 | 200 | 149 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.77e-07 | 156 | 149 | 7 | 5caefdc6cc86f2ac52abe8c8da821db14f476915 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.77e-07 | 156 | 149 | 7 | 758f57dc10fc5cad200bf5b310c10ec9b1405f23 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.48e-06 | 166 | 149 | 7 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-06 | 173 | 149 | 7 | 176d7dc103b8161c4e2d7dc74f2dc77ea1f2d2ed | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.73e-06 | 182 | 149 | 7 | 37547b36264090b49a193a8ef3a8d88e647f0b79 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.89e-06 | 192 | 149 | 7 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.02e-06 | 193 | 149 | 7 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 4.60e-06 | 197 | 149 | 7 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Proliferative_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.92e-06 | 199 | 149 | 7 | b65fbfed4a9938820cf900afd350b4ecb789b7b3 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 5.08e-06 | 200 | 149 | 7 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-05 | 163 | 149 | 6 | d2fcd6f561748f7d29a051c504f016952ba32d0f | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.67e-05 | 174 | 149 | 6 | 742c73c9e090848b464323cb17579b86658c6792 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.67e-05 | 174 | 149 | 6 | 7fed9722e64c60843092f2ba71256e3043011ef6 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.94e-05 | 177 | 149 | 6 | 36b5d29caa9cffbc0284f771a4db71aa72171a89 | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 3.03e-05 | 178 | 149 | 6 | 9a3581a0158dfa5a1cc942f8c532afb5e38b272a | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.13e-05 | 179 | 149 | 6 | af0b54c9ea0b6e4210f22dbb6e88ecd3276a5f86 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.33e-05 | 181 | 149 | 6 | ab0f300d14b62cef57f1b0bdae143b8dfe8e6975 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.33e-05 | 181 | 149 | 6 | beb2771820956be8b190c0088ae3c4efdb53c897 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-05 | 182 | 149 | 6 | 9edaccf1154cec92ca9a28e9b1f9075cfd422bfd | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 3.43e-05 | 182 | 149 | 6 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-05 | 182 | 149 | 6 | aba4c06d5d7618ac21b2695bca8e7a1346a91090 | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial-neuroendocrine_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.65e-05 | 184 | 149 | 6 | e0e5a553fb8c0947679634396d20c2ca8455b932 | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial-neuroendocrine_cell-neuroendocrine|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.65e-05 | 184 | 149 | 6 | c3b848e1438a84b3fac8a4e40f3db478cc84d970 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-lung_neuroendocrine_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-05 | 185 | 149 | 6 | 30263c558ee331e0879abcf8b4c2427ff05f9fe7 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-Neuroendocrine|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-05 | 185 | 149 | 6 | 1b000ca11970db8f347eb97ff44605d562aea70a | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.87e-05 | 186 | 149 | 6 | 56c139e679d640ea901ead657a8e8887e0fca098 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.87e-05 | 186 | 149 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.87e-05 | 186 | 149 | 6 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.99e-05 | 187 | 149 | 6 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.99e-05 | 187 | 149 | 6 | 3912bbb610a4a84791e9bda92a2d57a52c31d29e | |
| ToppCell | LPS_only-Unknown-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.26e-05 | 115 | 149 | 5 | ad5298c2ad8bf94fa13c2e50b0799e929473ef59 | |
| ToppCell | LPS_only-Unknown|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.26e-05 | 115 | 149 | 5 | 7a733f6987b40ec497a03734b79ed5355ad3a2fc | |
| ToppCell | LPS_only-Unknown-Endothelial-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.26e-05 | 115 | 149 | 5 | c67145d3cd9243994a141749b426ff2a6dcc8d93 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 4.36e-05 | 190 | 149 | 6 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.49e-05 | 191 | 149 | 6 | de2cd94ee88a7754f86d39469e38374d668210c7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-05 | 192 | 149 | 6 | 43228bddca2f606ddcae9731f04c6b1502c4b85a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-05 | 192 | 149 | 6 | f5463c6bcc5c69ac562bec028f7a105c471f2fbe | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.62e-05 | 192 | 149 | 6 | d0fb6885f023d55a2b7984c99db9c6463258f788 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.76e-05 | 193 | 149 | 6 | 4aa976b596830b585e8d9c808d5072ed23d13a7c | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.76e-05 | 193 | 149 | 6 | 173f1d83133f5ffa88e2a75d28835ad7acd2aa90 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 193 | 149 | 6 | 18e11d515147accef9aee26e934b358b445e18e2 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.76e-05 | 193 | 149 | 6 | efa91167dc7a59bf32addf90ffb7bf070b2a0151 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 193 | 149 | 6 | 7766f495f2f945802ef9a5b994cd00bb64d0dfe3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 193 | 149 | 6 | ce3e8cf30b7b4d5c7a8f3d64c21d81d2c3cab5c1 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.90e-05 | 194 | 149 | 6 | d2bafd31bb8333f66b6c714944bceb2f1aa11740 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.04e-05 | 195 | 149 | 6 | 26a3a5daf389606ef1ebb35533f12e60853b3a12 | |
| ToppCell | LV-03._Atrial_Cardiomyocyte|LV / Chamber and Cluster_Paper | 5.22e-05 | 120 | 149 | 5 | 3b77bd0e3630cdd45001cecf5e47660a90ebc92e | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.33e-05 | 197 | 149 | 6 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.33e-05 | 197 | 149 | 6 | ba6393671a980a1d439307601d18db70a1b1e1f3 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-MYL4+_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.33e-05 | 197 | 149 | 6 | 4797f414330316e2ac2cf7cd2570d991877d7a38 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.33e-05 | 197 | 149 | 6 | 5a63c2b824c7d0dbbc706e408459c9b9fe65daaa | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.33e-05 | 197 | 149 | 6 | f4f686d20821af3e6f859b96edc31827a430e3de | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.48e-05 | 198 | 149 | 6 | c82a151f9f1477d4a401457173b8d72af776c137 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 5.48e-05 | 198 | 149 | 6 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.48e-05 | 198 | 149 | 6 | dc63b56bb6291e527b172d603569376286262845 | |
| ToppCell | Healthy/Control|World / Disease group and Cell class | 5.64e-05 | 199 | 149 | 6 | 2623c42b3e79e401a485879b52e8bbcbc581544d | |
| ToppCell | distal-3-mesenchymal-Myofibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.64e-05 | 199 | 149 | 6 | 1f20addc0d138fec02ed6ca4c518169c568de263 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 5.64e-05 | 199 | 149 | 6 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | distal-mesenchymal-Myofibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.80e-05 | 200 | 149 | 6 | 069c8949b33ecfdb6da32992002d4060ff6082bc | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.80e-05 | 200 | 149 | 6 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_3|Control_saline / Treatment groups by lineage, cell group, cell type | 5.80e-05 | 200 | 149 | 6 | b0866b497aa71d06cef25f9a335fa584e95fa7e0 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | 5.80e-05 | 200 | 149 | 6 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Mucinous_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.45e-04 | 149 | 149 | 5 | 649eb3441fa859591ea85f1ed5fcf08af272a32b | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.45e-04 | 149 | 149 | 5 | a34d095b8e0fe59d69d84e4fd2fe4ccb82f92e4f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-04 | 152 | 149 | 5 | 0cb5f4dfae04e3f4eba502bbf229007d5fa3884d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-04 | 152 | 149 | 5 | ba89ffb5a8bb33c188f854f54b39123b6d73496a | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.64e-04 | 153 | 149 | 5 | 61fe71e32fc9c8cad875bc087aad0b0ff680bf45 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.64e-04 | 153 | 149 | 5 | 991782d111d66e25b40319d4e6dea40f2c2c0805 | |
| ToppCell | Striatum-Neuronal-Inhibitory|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.85e-04 | 157 | 149 | 5 | c41ff3fe9de7187575114febfe9bd8733366fb8a | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-TRGV5/7_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.96e-04 | 159 | 149 | 5 | 006076bac619bf14a4c98f1158ac336bd9908914 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.02e-04 | 160 | 149 | 5 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.08e-04 | 161 | 149 | 5 | 2849fbc9611af208241b33da3cd18290aafe426b | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-04 | 163 | 149 | 5 | 132aece9c79499b4bb3c2bde68d3d7202e1d8772 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 2.27e-04 | 164 | 149 | 5 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | NS-control-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.33e-04 | 165 | 149 | 5 | 8b2d43d7c4ee07bd999bd51bc15117ce1fbb2d86 | |
| ToppCell | control-Myeloid-pDC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.33e-04 | 165 | 149 | 5 | 243c74adf8d993ff92acbff2768bdc5a1693eca3 | |
| ToppCell | COVID-CD8-exh_CD4|COVID / Condition, Cell_class and T cell subcluster | 2.40e-04 | 166 | 149 | 5 | 4ca8c91b03d08489f244898cf9423b9d10348bc8 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.40e-04 | 166 | 149 | 5 | 1a3a15d1fc76bb91d832cdc6e3da0a6140b94b75 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-04 | 167 | 149 | 5 | 7f3224af9b30082b927a822b91f96e0c88151b4e | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-04 | 167 | 149 | 5 | a21a2b301d0a3d7a41e605f7a3c37548962a331d | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-04 | 167 | 149 | 5 | 0e746483773bde6582874a33591ab2a578d724eb | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.47e-04 | 167 | 149 | 5 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.47e-04 | 167 | 149 | 5 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-04 | 168 | 149 | 5 | de1042267407719f19eb3f580a5df0c9cd0e8273 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 170 | 149 | 5 | b4f2c05db2c2591561fd42febc72eed3b5e8f9fb | |
| ToppCell | Severe-B_naive-11|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.75e-04 | 171 | 149 | 5 | 7c2699f19ca38414447a286f7658f507882d57c2 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 2.83e-04 | 172 | 149 | 5 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-04 | 172 | 149 | 5 | 3f784aed340b50ddbec3f7dc0a5279180d38a2bb | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-04 | 173 | 149 | 5 | fc2602b2ce051cd4c33957d7e3d041ff8a529883 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-04 | 173 | 149 | 5 | 901b8e6909c1f3849906fad9cee17b8f0bab050d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.90e-04 | 173 | 149 | 5 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.98e-04 | 174 | 149 | 5 | 271c51d220842402975d97c86c9acfdbdf62a32c | |
| ToppCell | facs-Skin-nan-24m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 175 | 149 | 5 | f1166b567bca80dac3abe90c3dc544c831006640 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.06e-04 | 175 | 149 | 5 | da191dfb8a7f976a632a3a0b923942ab54f5c8c1 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.14e-04 | 176 | 149 | 5 | 2e1003dc373b14d27f0464d980453fdcfc1005f0 | |
| Computational | Genes in the cancer module 123. | 1.98e-04 | 247 | 89 | 9 | MODULE_123 | |
| Computational | Neighborhood of SMARCC1 | 2.35e-04 | 37 | 89 | 4 | GCM_SMARCC1 | |
| Computational | Neighborhood of AIP | 3.20e-04 | 40 | 89 | 4 | GCM_AIP | |
| Drug | Oxethazaine [126-27-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | MAPKAPK2 RNPEPL1 MINK1 RNF19B ADGRL1 ZYX JUND BRD4 KCNN1 ZFHX3 SF3A2 | 6.42e-08 | 194 | 149 | 11 | 4246_DN |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.86e-06 | 170 | 149 | 9 | 1050_DN | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 4.25e-06 | 188 | 149 | 9 | 6735_DN | |
| Drug | Cefalonium [5575-21-3]; Down 200; 8.8uM; PC3; HT_HG-U133A | 5.27e-06 | 193 | 149 | 9 | 4245_DN | |
| Drug | Carcinine [56897-53-1]; Down 200; 22uM; PC3; HT_HG-U133A | 5.27e-06 | 193 | 149 | 9 | 4225_DN | |
| Drug | o-xylylene dibromide | 5.41e-06 | 6 | 149 | 3 | CID000066665 | |
| Drug | etheno-NAD | 5.58e-06 | 104 | 149 | 7 | CID005288160 | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 5.73e-06 | 195 | 149 | 9 | 7225_DN | |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Up 200; 11.8uM; HL60; HT_HG-U133A | 6.22e-06 | 197 | 149 | 9 | 2353_UP | |
| Drug | Mephenesin [59-47-2]; Up 200; 22uM; HL60; HT_HG-U133A | 6.48e-06 | 198 | 149 | 9 | 2342_UP | |
| Drug | deoxynivalenol | IL11 EVL BAG3 AR SF1 STRIP1 BPTF SETDB1 JUND RBM25 EIF4G1 SMARCC2 PALLD | 1.75e-05 | 481 | 149 | 13 | ctd:C007262 |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.06e-05 | 175 | 149 | 8 | 1058_DN | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.23e-05 | 177 | 149 | 8 | 985_DN | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 2.33e-05 | 178 | 149 | 8 | 3998_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 2.42e-05 | 179 | 149 | 8 | 4585_DN | |
| Drug | polyproline | 2.56e-05 | 295 | 149 | 10 | CID000439587 | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A | 3.71e-05 | 190 | 149 | 8 | 4274_UP | |
| Drug | Chlorpromazine hydrochloride [69-09-0]; Up 200; 11.2uM; HL60; HT_HG-U133A | 4.14e-05 | 193 | 149 | 8 | 1864_UP | |
| Drug | AG-012559 [369370-06-9]; Up 200; 10uM; PC3; HT_HG-U133A | 4.14e-05 | 193 | 149 | 8 | 6920_UP | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Down 200; 7.8uM; PC3; HG-U133A | 4.14e-05 | 193 | 149 | 8 | 1958_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; PC3; HG-U133A | 4.30e-05 | 194 | 149 | 8 | 433_DN | |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; PC3; HT_HG-U133A | 4.30e-05 | 194 | 149 | 8 | 4248_DN | |
| Drug | Indoprofen [31842-01-0]; Down 200; 14.2uM; PC3; HT_HG-U133A | 4.30e-05 | 194 | 149 | 8 | 4249_DN | |
| Drug | H-89, Dihydrochloride; Up 200; 0.5uM; PC3; HT_HG-U133A | 4.30e-05 | 194 | 149 | 8 | 6921_UP | |
| Drug | AC1L974K | 4.36e-05 | 11 | 149 | 3 | CID000439320 | |
| Drug | diclofenac sodium; Down 200; 10uM; MCF7; HG-U133A | 4.46e-05 | 195 | 149 | 8 | 333_DN | |
| Drug | Famprofazone [22881-35-2]; Up 200; 10.6uM; PC3; HT_HG-U133A | 4.46e-05 | 195 | 149 | 8 | 4309_UP | |
| Drug | Doxylamine succinate [562-10-7]; Down 200; 10.2uM; PC3; HT_HG-U133A | 4.46e-05 | 195 | 149 | 8 | 4235_DN | |
| Drug | Nifenazone [2139-47-1]; Down 200; 13uM; PC3; HT_HG-U133A | 4.46e-05 | 195 | 149 | 8 | 2122_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A | 4.62e-05 | 196 | 149 | 8 | 5569_DN | |
| Drug | Pivmecillinam hydrochloride [32887-03-9]; Down 200; 8.4uM; PC3; HT_HG-U133A | 4.62e-05 | 196 | 149 | 8 | 7312_DN | |
| Drug | Betamethasone [378-44-9]; Down 200; 10.2uM; PC3; HT_HG-U133A | 4.62e-05 | 196 | 149 | 8 | 6728_DN | |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Down 200; 9uM; HL60; HT_HG-U133A | 4.62e-05 | 196 | 149 | 8 | 2388_DN | |
| Drug | radicicol; Up 200; 0.1uM; SKMEL5; HG-U133A | 4.62e-05 | 196 | 149 | 8 | 493_UP | |
| Drug | Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; PC3; HT_HG-U133A | 4.62e-05 | 196 | 149 | 8 | 4227_DN | |
| Drug | Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 4.62e-05 | 196 | 149 | 8 | 5341_UP | |
| Drug | Hymecromone [90-33-5]; Down 200; 22.8uM; MCF7; HT_HG-U133A | 4.62e-05 | 196 | 149 | 8 | 3383_DN | |
| Drug | Alcuronium chloride [15180-03-7]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 4.62e-05 | 196 | 149 | 8 | 4409_DN | |
| Drug | Moricizine hydrochloride [31883-05-3]; Down 200; 8.6uM; HL60; HT_HG-U133A | 4.96e-05 | 198 | 149 | 8 | 2959_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A_EA | 4.96e-05 | 198 | 149 | 8 | 1020_DN | |
| Drug | Etanidazole [22668-01-5]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 4.96e-05 | 198 | 149 | 8 | 6211_DN | |
| Drug | Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 4.96e-05 | 198 | 149 | 8 | 7035_UP | |
| Drug | Nitrofurantoin [67-20-9]; Up 200; 16.8uM; PC3; HT_HG-U133A | 4.96e-05 | 198 | 149 | 8 | 7373_UP | |
| Drug | iloprost; Up 200; 1uM; SKMEL5; HG-U133A | 5.14e-05 | 199 | 149 | 8 | 496_UP | |
| Drug | Leucomisine [17946-87-1]; Up 200; 16.2uM; PC3; HT_HG-U133A | 5.14e-05 | 199 | 149 | 8 | 7125_UP | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; PC3; HT_HG-U133A | 5.33e-05 | 200 | 149 | 8 | 2061_DN | |
| Drug | AC1L1B3K | 5.79e-05 | 12 | 149 | 3 | CID000001268 | |
| Drug | CID5320302 | 1.27e-04 | 3 | 149 | 2 | CID005320302 | |
| Drug | SAHA; Down 200; 10uM; PC3; HT_HG-U133A | 1.58e-04 | 175 | 149 | 7 | 1220_DN | |
| Drug | 1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one | 1.79e-04 | 373 | 149 | 10 | ctd:C540355 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.88e-04 | 180 | 149 | 7 | 1793_DN | |
| Drug | Prednisone [53-03-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.53e-04 | 189 | 149 | 7 | 4400_DN | |
| Drug | Mepenzolate bromide [76-90-4]; Up 200; 9.6uM; PC3; HT_HG-U133A | 2.53e-04 | 189 | 149 | 7 | 4304_UP | |
| Drug | butyl peroxide | 2.53e-04 | 4 | 149 | 2 | CID000077458 | |
| Drug | Calciferol [50-14-6]; Down 200; 10uM; PC3; HT_HG-U133A | 2.70e-04 | 191 | 149 | 7 | 6746_DN | |
| Drug | ICI182,780; Down 200; 1uM; MCF7; HT_HG-U133A | 2.70e-04 | 191 | 149 | 7 | 5964_DN | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 10uM; PC3; HT_HG-U133A | 2.78e-04 | 192 | 149 | 7 | 4288_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A | 2.87e-04 | 193 | 149 | 7 | 1647_UP | |
| Drug | Carbamazepine [298-46-4]; Down 200; 17uM; PC3; HT_HG-U133A | 2.87e-04 | 193 | 149 | 7 | 1805_DN | |
| Drug | 0316684-0000 [391209-55-5]; Up 200; 10uM; PC3; HT_HG-U133A | 2.87e-04 | 193 | 149 | 7 | 7057_UP | |
| Drug | Zidovudine, AZT [30516-87-1]; Down 200; 15uM; PC3; HT_HG-U133A | 2.87e-04 | 193 | 149 | 7 | 6733_DN | |
| Drug | Phenacetin [62-44-2]; Down 200; 22.4uM; MCF7; HT_HG-U133A | 2.96e-04 | 194 | 149 | 7 | 4111_DN | |
| Drug | Acetohexamide [968-81-0]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 2.96e-04 | 194 | 149 | 7 | 1707_DN | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A | 2.96e-04 | 194 | 149 | 7 | 4331_DN | |
| Drug | Sulfamethizole [144-82-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 2.96e-04 | 194 | 149 | 7 | 6272_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; PC3; HT_HG-U133A | 2.96e-04 | 194 | 149 | 7 | 1209_DN | |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; PC3; HT_HG-U133A | 2.96e-04 | 194 | 149 | 7 | 3807_DN | |
| Drug | Indapamide [26807-65-8]; Down 200; 10.6uM; PC3; HT_HG-U133A | 2.96e-04 | 194 | 149 | 7 | 4335_DN | |
| Drug | Epivincamine [6835-99-0]; Up 200; 11.2uM; HL60; HG-U133A | 2.96e-04 | 194 | 149 | 7 | 1783_UP | |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; PC3; HT_HG-U133A | 2.96e-04 | 194 | 149 | 7 | 4242_DN | |
| Drug | Scoulerine [6451-73-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 2.96e-04 | 194 | 149 | 7 | 2891_DN | |
| Drug | Benfotiamine [22457-89-2]; Up 200; 8.6uM; PC3; HT_HG-U133A | 3.06e-04 | 195 | 149 | 7 | 4312_UP | |
| Drug | Berberine chloride [633-65-8]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 3.06e-04 | 195 | 149 | 7 | 2770_UP | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 3.06e-04 | 195 | 149 | 7 | 5571_DN | |
| Drug | ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A | 3.06e-04 | 195 | 149 | 7 | 6918_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; PC3; HT_HG-U133A | 3.06e-04 | 195 | 149 | 7 | 1214_DN | |
| Drug | Pimethixene maleate [13187-06-9]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 3.06e-04 | 195 | 149 | 7 | 7468_UP | |
| Drug | Cefadroxil [50370-12-2]; Up 200; 11uM; HL60; HT_HG-U133A | 3.15e-04 | 196 | 149 | 7 | 1323_UP | |
| Drug | Diprophylline [479-18-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 3.15e-04 | 196 | 149 | 7 | 5063_DN | |
| Drug | Epicatechin-(-) [154-23-4]; Down 200; 13.8uM; PC3; HT_HG-U133A | 3.15e-04 | 196 | 149 | 7 | 4594_DN | |
| Drug | Hydroflumethiazide [135-09-1]; Up 200; 12uM; MCF7; HT_HG-U133A | 3.15e-04 | 196 | 149 | 7 | 1687_UP | |
| Drug | Metrizamide [31112-62-6]; Down 200; 5uM; MCF7; HT_HG-U133A | 3.15e-04 | 196 | 149 | 7 | 3255_DN | |
| Drug | Deptropine citrate [2169-75-7]; Up 200; 7.6uM; HL60; HT_HG-U133A | 3.15e-04 | 196 | 149 | 7 | 3144_UP | |
| Drug | Hesperetin [520-33-2]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 3.15e-04 | 196 | 149 | 7 | 1531_DN | |
| Drug | Seneciphylline [480-81-9]; Down 200; 12uM; PC3; HT_HG-U133A | 3.15e-04 | 196 | 149 | 7 | 4238_DN | |
| Drug | Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 3.15e-04 | 196 | 149 | 7 | 6273_DN | |
| Drug | Adamantamine fumarate [80789-67-9]; Up 200; 9.6uM; HL60; HT_HG-U133A | 3.15e-04 | 196 | 149 | 7 | 1344_UP | |
| Drug | Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 3.25e-04 | 197 | 149 | 7 | 6011_DN | |
| Drug | aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A | 3.25e-04 | 197 | 149 | 7 | 6964_UP | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 3.25e-04 | 197 | 149 | 7 | 4134_UP | |
| Drug | Alclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 3.25e-04 | 197 | 149 | 7 | 6229_DN | |
| Drug | Sulfachloropyridazine [80-32-0]; Up 200; 14uM; HL60; HT_HG-U133A | 3.25e-04 | 197 | 149 | 7 | 2191_UP | |
| Drug | Idazoxan hydrochloride [79944-56-2]; Down 200; 16.6uM; PC3; HT_HG-U133A | 3.25e-04 | 197 | 149 | 7 | 6747_DN | |
| Drug | Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 3.25e-04 | 197 | 149 | 7 | 3415_DN | |
| Drug | Meticrane [1084-65-7]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 3.25e-04 | 197 | 149 | 7 | 1671_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A | 3.25e-04 | 197 | 149 | 7 | 5211_DN | |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A | 3.25e-04 | 197 | 149 | 7 | 6863_UP | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; PC3; HT_HG-U133A | 3.25e-04 | 197 | 149 | 7 | 4299_UP | |
| Drug | Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; PC3; HT_HG-U133A | 3.25e-04 | 197 | 149 | 7 | 4501_DN | |
| Drug | Chlorogenic acid [327-97-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 3.25e-04 | 197 | 149 | 7 | 4142_DN | |
| Disease | serum gamma-glutamyl transferase measurement | REPS1 CPSF6 BICRA PDX1 ZYX SEMA4G BPTF RBM25 PBRM1 ENAH SYN2 MICAL3 TAF4 PRRC2A | 1.29e-04 | 914 | 141 | 14 | EFO_0004532 |
| Disease | Bulbospinal Neuronopathy | 1.35e-04 | 4 | 141 | 2 | C0393547 | |
| Disease | Neoplasm of the genitourinary tract | 2.01e-04 | 24 | 141 | 3 | cv:C0042065 | |
| Disease | anti-human herpes virus 7 antibody measurement | 2.25e-04 | 5 | 141 | 2 | EFO_0011038 | |
| Disease | spinal muscular atrophy (is_implicated_in) | 3.36e-04 | 6 | 141 | 2 | DOID:12377 (is_implicated_in) | |
| Disease | household income | 6.70e-04 | 304 | 141 | 7 | EFO_0009695 | |
| Disease | C-reactive protein measurement | POU3F2 HSF5 CRK SCAF4 BPTF RBM25 PCDH15 SMARCC2 MICAL3 SCAF11 TNKS IRS2 TAF4 BSN ARAP1 | 6.77e-04 | 1206 | 141 | 15 | EFO_0004458 |
| Disease | Mitral valve prolapse | 6.79e-04 | 36 | 141 | 3 | HP_0001634 | |
| Disease | amnestic disorder (implicated_via_orthology) | 7.98e-04 | 9 | 141 | 2 | DOID:10914 (implicated_via_orthology) | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 7.98e-04 | 9 | 141 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | Coffin-Siris syndrome (implicated_via_orthology) | 7.98e-04 | 9 | 141 | 2 | DOID:1925 (implicated_via_orthology) | |
| Disease | Malignant tumor of prostate | 7.98e-04 | 9 | 141 | 2 | cv:C0376358 | |
| Disease | feeling nervous measurement | 8.18e-04 | 87 | 141 | 4 | EFO_0009597 | |
| Disease | tauopathy (implicated_via_orthology) | 9.95e-04 | 10 | 141 | 2 | DOID:680 (implicated_via_orthology) | |
| Disease | sexual dysfunction | 1.21e-03 | 11 | 141 | 2 | EFO_0004714 | |
| Disease | Familial dilated cardiomyopathy | 1.23e-03 | 44 | 141 | 3 | C0340427 | |
| Disease | Intellectual Disability | 1.43e-03 | 447 | 141 | 8 | C3714756 | |
| Disease | trauma exposure measurement | 1.45e-03 | 172 | 141 | 5 | EFO_0010703 | |
| Disease | left atrial volume measurement | 1.45e-03 | 12 | 141 | 2 | EFO_0600035 | |
| Disease | Alopecia, Male Pattern | 2.29e-03 | 15 | 141 | 2 | C4083212 | |
| Disease | Androgenetic Alopecia | 2.29e-03 | 15 | 141 | 2 | C0162311 | |
| Disease | Female pattern alopecia (disorder) | 2.29e-03 | 15 | 141 | 2 | C0263477 | |
| Disease | urate measurement, spine bone mineral density | 2.72e-03 | 58 | 141 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | Prostatic Neoplasms | 2.91e-03 | 616 | 141 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.91e-03 | 616 | 141 | 9 | C0376358 | |
| Disease | syndrome (implicated_via_orthology) | 3.30e-03 | 18 | 141 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | Pseudopelade | 3.68e-03 | 19 | 141 | 2 | C0086873 | |
| Disease | Alopecia | 3.68e-03 | 19 | 141 | 2 | C0002170 | |
| Disease | word reading | 3.76e-03 | 65 | 141 | 3 | EFO_0005300 | |
| Disease | Global developmental delay | 3.87e-03 | 133 | 141 | 4 | C0557874 | |
| Disease | Deaf Mutism | 4.07e-03 | 20 | 141 | 2 | C4082305 | |
| Disease | Deafness, Acquired | 4.07e-03 | 20 | 141 | 2 | C0751068 | |
| Disease | Hearing Loss, Extreme | 4.07e-03 | 20 | 141 | 2 | C0086395 | |
| Disease | Complete Hearing Loss | 4.07e-03 | 20 | 141 | 2 | C0581883 | |
| Disease | Bilateral Deafness | 4.07e-03 | 20 | 141 | 2 | C3665473 | |
| Disease | Prelingual Deafness | 4.07e-03 | 20 | 141 | 2 | C0011052 | |
| Disease | dilated cardiomyopathy | 4.07e-03 | 20 | 141 | 2 | EFO_0000407 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 4.52e-03 | 139 | 141 | 4 | DOID:3908 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PKPEGFLPPPFPPPG | 546 | Q01844 | |
| APPPDPGFPAPSPPP | 1301 | Q6ZSZ5 | |
| GPQAYGPPAPPPAPP | 26 | P47902 | |
| QPGRSPPPPPPPEPS | 271 | P0C7U0 | |
| QATQTAPPPPPPPPP | 651 | P46379 | |
| PPPPQGQQPPHPPPG | 1011 | O60885 | |
| GGPPEAPPAQPPPPP | 1401 | O14514 | |
| PPPKPPSPPAPGAPV | 186 | P17405 | |
| SEALPPPPPAPPGPP | 1406 | O94910 | |
| KAAAPGPCPPPPPPP | 316 | Q14956 | |
| LPAPPDDFLPPPPPP | 546 | Q7Z5R6 | |
| PPPPPPAPAPAPVPD | 601 | Q7Z5R6 | |
| NPPPPPVPPPPASFP | 481 | O75909 | |
| PVPPPPASFPPPAIP | 486 | O75909 | |
| PPPAVPPGGQPPVPP | 546 | O75909 | |
| APAPPPPPPPPTSGP | 21 | Q12830 | |
| CPPVTPAPPAPPAPP | 2796 | Q12830 | |
| PPPPPPDQFAPPGVP | 296 | Q96EP5 | |
| QTPVPPQPPQPPPGP | 51 | Q09019 | |
| GMPPLPPPQQPPPPS | 176 | Q9Y2D1 | |
| GPRPPVPPSPAQPPP | 66 | P46108 | |
| PPPPPLPPGQPVPTA | 601 | Q15032 | |
| AAAEPPAPPPPPPPE | 16 | P06400 | |
| PPPPPPPGAEPACPG | 116 | Q8NDT2 | |
| PPPQPPPPPQAGLPQ | 46 | Q5T481 | |
| IPPPQFPGFPPPVPP | 21 | P49756 | |
| APASWQPPPPPQPPP | 136 | Q8TE59 | |
| PPPPLPNSPAPPNPG | 926 | Q68DA7 | |
| PTPAPPPPCFPVPPP | 901 | Q9H3S7 | |
| PPPCFPVPPPQPLPT | 906 | Q9H3S7 | |
| GPVPQPACPPPGPAP | 626 | Q13164 | |
| AGPPELPPPPPPAEP | 1186 | Q8WXD9 | |
| PPGQQAPPPYPGPHP | 1566 | Q86U86 | |
| APPPYPGPHPAGPPV | 1571 | Q86U86 | |
| PSSPPPPPPPGEEPA | 1456 | Q7RTP6 | |
| QPQPPPPPPEEPGAP | 11 | Q8NEZ4 | |
| PVPFPAPAPPPQPPT | 11 | P49137 | |
| PPPPPPPPPEEYKSQ | 1181 | Q5JU85 | |
| PPPLPPRPGPGPQDQ | 511 | Q92952 | |
| SFPPPPPPPGTQLPP | 436 | B1AK53 | |
| PPPGYPAPKPPVGPQ | 451 | B1AK53 | |
| AAEPVPFPPPPPPGA | 216 | P17535 | |
| APQYPGRGPPPAPPP | 741 | Q96Q04 | |
| PPEPPGPPGFPRVPS | 1606 | Q9UPA5 | |
| PPLPPPGPPPLFENE | 236 | P40123 | |
| PAVGSPPAPPPPPVP | 926 | Q5SYE7 | |
| QPPPDPPAPPLAPPS | 151 | P20809 | |
| QPPPPPPHPFPGALG | 41 | P52945 | |
| RPGPPPPQPPPPAPF | 11 | Q8N8D1 | |
| PPQPPPPAPFGCPPP | 16 | Q8N8D1 | |
| PPAPFGCPPPPLPSP | 21 | Q8N8D1 | |
| GCPPPPLPSPAFPPP | 26 | Q8N8D1 | |
| PPLPPPPPQCRPFPG | 86 | Q8N8D1 | |
| PARPEDTPPAPPPPP | 341 | Q6PJ61 | |
| PPPPPPEPARPAVPG | 101 | Q14766 | |
| PVSCSGPPPPPPPPV | 176 | Q9UI08 | |
| ATPPAGPPPAPPPPA | 36 | Q8IVB5 | |
| PAPPPPPPPVSAPAA | 131 | P56270 | |
| PPPPAPQPQPTPQPG | 401 | Q99958 | |
| NFPLALAGPPPPPPP | 366 | P10275 | |
| VAAPPVPPPPPTPFP | 441 | Q05215 | |
| PAHPPPINPPFPPGP | 26 | Q9NZ81 | |
| PINPPFPPGPCPPPP | 31 | Q9NZ81 | |
| PGSSAEPPPPPPPPP | 431 | Q27J81 | |
| PPPPPLPAAPPAPEF | 81 | P14652 | |
| AACRDPGPPPPPPPP | 66 | P17483 | |
| PPQQHYAPPPPPPPP | 336 | Q75N03 | |
| PPYMNHPPPGPPPPQ | 396 | Q75N03 | |
| PPSPPFPPPPAFPEL | 686 | Q8WX93 | |
| PDVFPLPPPPPPLPS | 816 | Q8WX93 | |
| PPGPPGAAPPPPRAP | 66 | Q8N414 | |
| EPGLPPQPQPPPPPL | 1261 | Q9Y4H2 | |
| PQPQPPPPPLPQPGD | 1266 | Q9Y4H2 | |
| VPAPAPVAAPPPPPP | 1426 | Q96QU1 | |
| PVAAPPPPPPPPPGA | 1431 | Q96QU1 | |
| PSPPPAPAPLAPPPD | 1756 | Q96QU1 | |
| PPAPPLAFLAPPPPP | 216 | Q5T0Z8 | |
| PPPPPVPAPAPPAPA | 226 | Q5T0Z8 | |
| APPPPPPQPPAPEAE | 26 | Q6TDP4 | |
| PPPPFPAGQTPPRPP | 226 | Q16630 | |
| PPQQGPPPPPGPFPP | 311 | Q16630 | |
| PPPAPPPAPAPAPAI | 356 | Q8IWX8 | |
| SLPPPPPPAPQPGPG | 221 | P23610 | |
| PGPPFAGPQPPPPPA | 186 | P31277 | |
| AGPQPPPPPAPPQPE | 191 | P31277 | |
| LPPPPPPAPGSAPPA | 306 | Q86UU0 | |
| GPPGPPAVMPPTPPP | 566 | P27658 | |
| PPAPSPGLPQPAFPP | 11 | Q04637 | |
| GPEPPPEAQPSPPPP | 241 | Q9Y5N1 | |
| APAAPAAPPPPPPPP | 61 | Q5VSG8 | |
| PAPAPPPKPASPGPP | 26 | P12980 | |
| KPPQGPPPPPPPSCA | 331 | Q9P267 | |
| GPPQPPPPPPPEESS | 11 | Q16760 | |
| PPPPPPPPEYGPHAD | 366 | P14866 | |
| ASVALPPPPGPPPPP | 326 | Q8N8S7 | |
| VPPAPVPCPPPSPGP | 366 | O95817 | |
| PPRPPPPPPPTGQMN | 1346 | Q9NZM4 | |
| PPPPQPQPPPEGGAV | 226 | Q6SPF0 | |
| PFPTPPPPPPPGEHS | 1266 | Q5VT52 | |
| FGPGVPPPPPPPPFL | 711 | O95104 | |
| PPPPPPPPFLRPGFN | 716 | O95104 | |
| SQPPPGFMPPPVPPP | 686 | Q9UPN6 | |
| SVSQGLPPPPPPPPP | 1271 | Q99590 | |
| ATPAPGPPPPPPPAP | 16 | Q9UL51 | |
| PAPPPGPGPAPPQHP | 41 | Q9UL51 | |
| GPPPPPPPPSLHPFG | 796 | Q8NFZ4 | |
| PPQPPPPPPQGPDVK | 136 | P20264 | |
| PPPPPAEAREPPAPP | 71 | Q9BTV7 | |
| PPAPPPPEPPTGLPA | 81 | Q9BTV7 | |
| PANEPPPPGPMPPAP | 16 | Q96G74 | |
| PGPGPAPAPAPPPAP | 491 | Q96RD6 | |
| PPPQQPPPPPSYSPA | 706 | Q9BUJ2 | |
| PSPVPGPLPPPPPAE | 46 | Q01101 | |
| PGPYPAPPPPQAPGA | 171 | Q8NDC0 | |
| APPPPQAPGAAPPVP | 176 | Q8NDC0 | |
| PKPPGPPAQPPGPPN | 716 | Q8N4C8 | |
| PAPAAPAAAPPPPPP | 261 | O00268 | |
| PQQPPPPPPPGPGAA | 31 | Q92777 | |
| QPPPPAGPRPEPHGP | 171 | Q4G112 | |
| PGPAPPPPLPAFPEA | 111 | Q9HAU8 | |
| PPPPAAQPPPAPAPA | 56 | Q6ZMZ0 | |
| PDNTAPPPPPPRPQP | 541 | Q96D71 | |
| PQPPAPRPDPPAPAP | 446 | A5PKW4 | |
| APPSAPPPPPPPPQG | 536 | Q9BXQ6 | |
| SPPPPPPPPPPAEDG | 721 | Q8N3X1 | |
| PPPPQPGSGPAPPAP | 16 | Q15270 | |
| PLAPPPPGAPPSPAP | 1136 | P48634 | |
| PRGPYPPGPLAPPQP | 26 | P02814 | |
| APPQPFGPGFVPPPP | 36 | P02814 | |
| PPPPPPAAAQPPPGA | 21 | Q5VSL9 | |
| PPPPPPPRQPGAAPA | 826 | Q9H0K1 | |
| GLKFNGPPPPPPPPP | 211 | Q16637 | |
| PPPPQPGFPMPPPLP | 696 | Q9UPS6 | |
| PPPPPPGPDPAADPA | 6 | Q9H6T0 | |
| PPAMPSPPPPPPPAA | 1506 | Q9ULL5 | |
| HQQPPPPPPPQGPPG | 236 | P20265 | |
| PPPQQQPPPPPPADG | 1076 | Q92922 | |
| QPPPPPPADGVPPPP | 1081 | Q92922 | |
| PPADGVPPPPAPGPP | 1086 | Q92922 | |
| PPPPPPPAPSIIPFG | 1086 | Q8TAQ2 | |
| PSGPPGPPQLPPPAP | 271 | Q15428 | |
| PQPTAPPAPPFPPAP | 451 | Q15047 | |
| PPAPPFPPAPPLSPQ | 456 | Q15047 | |
| PPPPPPPFLNSPPLG | 276 | Q9Y2V3 | |
| PAPAAPQPGPDPPPG | 1656 | Q9Y566 | |
| GPPQPPSPPPCPPEI | 201 | Q96P48 | |
| SQALPAPAPPPPPPP | 66 | Q3C1V1 | |
| PPPAGKPQGPPPPPQ | 281 | Q04118 | |
| CPSPLPPPPAPPKGP | 331 | O15417 | |
| PPPPAPPKGPPAPPA | 336 | O15417 | |
| AQPPPPPGPPQQLPP | 221 | Q9UPR6 | |
| PPGPPQQLPPPPAPA | 226 | Q9UPR6 | |
| IIPGEGAPAPPPPPP | 756 | Q9NTN9 | |
| PPPPPPPPPAELTNG | 766 | Q9NTN9 | |
| AQPAAPPQPAPPPPP | 71 | A1L020 | |
| PPQPAPPPPPAAPPA | 76 | A1L020 | |
| APPAPPARPPPGPGP | 266 | Q2MJR0 | |
| APGASAPPPPPPPPL | 21 | O95271 | |
| PPGPLAPPPPPCFPF | 31 | Q99954 | |
| PPPPPPPPGLPTYEQ | 166 | O14669 | |
| PQQPPPPPPPQAPEG | 301 | Q9UPY6 | |
| SGPPPPPPPPVIPSA | 341 | Q9UPY6 | |
| PVPARPPPPTNFPPP | 231 | Q5JSH3 | |
| MPASPPPGPPPAPEP | 451 | Q9P1Z0 | |
| QPQPDPPPVPPGPTP | 196 | Q6NWY9 | |
| PPPPPPQPPQIPEGS | 1556 | Q9UGU0 | |
| GPKPGFAPPPAPPPP | 311 | Q9Y6W5 | |
| FAPPPAPPPPPPPMI | 316 | Q9Y6W5 | |
| QPPAPPQPAPPPPGC | 771 | Q8WYQ9 | |
| PPPEDFPLPPPPLAG | 66 | Q15942 | |
| PPYWQPGPPGPPAPP | 181 | Q8TF01 | |
| ASSPPPQPQPPPPPA | 1316 | Q9H7P9 | |
| PGPAAAPTPPPCPPP | 96 | Q70CQ4 | |
| PPPPHNSGPPPPPAR | 291 | O00401 | |
| PPPPYRQPPGVPNGP | 251 | Q8TF74 | |
| PPTNAAPPAAPPPPP | 341 | Q96K80 | |
| GSPPPPPPPPPARDG | 156 | Q7RTU7 | |
| PVPPSCPAPQPRPPP | 416 | A7MCY6 | |
| APPPPPPPPPGSAGM | 581 | Q15637 | |
| PPPPPLPAAPPQPAS | 2046 | Q15911 | |
| PLPQPPPPAAAPAPG | 341 | Q5EBL2 | |
| PGSPDPPPAPPAPAP | 771 | Q9P206 | |
| KPPAPPGAPEPPGPF | 471 | P28698 | |
| LQPPFPPPPPPGDPT | 156 | Q8NBZ9 | |
| FQPPPPPPPAPSGDA | 251 | Q96SB3 |